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Abstract
Background Dysregulation of the hypothalamic-pituitary-
adrenal (HPA) axis is associated with diverse adverse health out-
comes, making it an important therapeutic target. Measurement
of the diurnal rhythm of cortisol secretion provides awindow into
this system. At present, no guidelines exist for the optimal use of
this biomarker within randomised controlled trials (RCTs).
Purpose The aim of this study is to describe the ways in
which salivary diurnal cortisol has been measured within
RCTs of health or behavioural interventions in adults.
Methods Six electronic databases (up to May 21, 2015) were
systematically searched for RCTs which used salivary diurnal
cortisol as an outcome measure to evaluate health or behav-
ioural interventions in adults. A narrative synthesis was un-
dertaken of the findings in relation to salivary cortisol meth-
odology and outcomes.
Results From 78 studies that fulfilled the inclusion criteria, 30
included healthy participants (38.5 %), 27 included patients
with physical disease (34.6 %) and 21 included patients with
psychiatric disease (26.9 %). Psychological therapies were most
commonly evaluated (n=33, 42.3 %). There was substantial
heterogeneity across studies in relation to saliva collection pro-
tocols and reported cortisol parameters. Only 39 studies (50 %)
calculated a rhythm parameter such as the diurnal slope or the
cortisol awakening response (CAR). Patterns of change in cor-
tisol parameters were inconsistent bothwithin and across studies
and there was low agreement with clinical findings.
Conclusions Salivary diurnal cortisol is measured inconsis-
tently across RCTs, which is limiting the interpretation of
findings within and across studies. This indicates a need for
more validation work, along with consensus guidelines.
Keywords Salivary cortisol . Diurnal rhythm . Randomized
controlled trial . Systematic review . Intervention
Introduction
The hypothalamic-pituitary-adrenal (HPA) axis is known to
be an important pathway in the regulation of the physiological
stress response. HPA axis dysregulation has been shown to be
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associated with important health outcomes including psychi-
atric illness [1], cardiovascular mortality [2], cancer prognosis
[3, 4], and frailty and cognitive decline [5]. These associations
are thought to be mediated by the deleterious effects of chron-
ic stress on HPA axis function [6], with secondary effects on
metabolic, immune and psychobiological systems [7]. The
many associations between HPA axis dysregulation and
markers of health status suggest that HPA axis modulation
by therapeutic interventions may have a role in disease treat-
ment and prevention. In order to demonstrate this, accurate
and feasible measurement of HPA axis function within
randomised controlled trials (RCTs) is necessary.
The use of salivary cortisol as a biomarker of stress and
HPA axis function is a well-established practice in stress re-
search, dating back to at least 20 years [8]. Due to marked
diurnal variation in cortisol hormone secretion throughout the
day [9], a variety of methods of salivary cortisol collection and
analysis have been explored and utilised in an attempt to iden-
tify the most representative summary measure of HPA axis
function. Essentially, two broad approaches have been taken
[9]. The first approach is to measure HPA axis reactivity to a
standardised acute stressor. Whilst this approach is useful, in-
terpretation of the results is limited by the need to consider the
time of day the stressor is administered, as well as the nature of
the stressor. The second approach is to measure basal or
unstimulated HPA axis function; thus avoiding the need to
administer a stressor.
Measurement of basal HPA axis function has evolved con-
siderably over the past two decades, as theoretical and empir-
ical knowledge regarding the stress system, cortisol measure-
ment and disease associations has increased. In the early days
of salivary cortisol research, a single salivary cortisol measure,
collected at a pre-specified time, was used to estimate basal
HPA axis function, but this methodology proved to be unreli-
able, with large intra-individual and inter-individual variation
[10]. Another common approach was to measure average or
total cortisol exposure over a 12–24-h period [11]. Whilst this
approach provides a summary measure, it does not accommo-
date the complex nature of HPA axis aberration, with both
hypocortisolism and hypercortisolism now recognised to be
linked to chronic stress [12]. Increasingly, therefore, there has
been a move towards measuring the circadian rhythm of diur-
nal cortisol secretion, rather than focusing on absolute cortisol
concentration [11].
Typically, under basal conditions, a healthy HPA axis is
characterised by a distinctive circadian pattern of cortisol se-
cretion, whereby cortisol rises to a peak within 30–45 min of
waking and then falls to a nadir during sleep at approximately
midnight [9, 11]. The major measurable parameters of this
diurnal rhythm are (1) the cortisol awakening response
(CAR), which is the rise in cortisol during the first 30–
45 min following awakening [9], and (2) the diurnal cortisol
slope, which is the rate of decline in cortisol levels across the
day, from morning to evening [11]. This normal rhythm be-
comes disrupted when the HPA axis becomes dysregulated
[9, 13], the pattern of disruption varying depending on the
context or condition studied. In general, an abnormal cortisol
awakening response, both abnormally large and small, or a
flattened diurnal cortisol slope appear to be consistent markers
of HPA axis dysfunction [11]. Importantly, there is evidence
that these parameters are independently regulated, with the
cortisol awakening response being mediated by an extra-
pituitary pathway to the adrenal from the suprachiasmatic nu-
cleus [14]. Thus, these parameters are believed to represent
different aspects of HPA axis function [14–16].
Due to the many possible ways of measuring salivary cor-
tisol as a biomarker in stress research, it is necessary to reach
consensus regarding the most appropriate methodology, so
that the results of different research studies can be compared
and so as to avoid waste in the design, conduct and reporting
of studies. Adam and Kumari [11] have reviewed the use of
salivary diurnal cortisol in epidemiological studies and have,
accordingly, published recommendations. They found that the
cortisol awakening response, the cortisol slope and the area
under the daytime cortisol curve (AUC) were most commonly
measured within large epidemiological studies and have been
most robustly linked with psychosocial phenomena and health
outcomes, implying clinical relevance. They recommend that
these parameters should each be assessed as separate indica-
tors of HPA axis function and that the cortisol collection
schedule be sufficient to measure, at minimum, the cortisol
awakening response and the diurnal slope over more than
1 day.
There is no guidance available for the measurement of
salivary diurnal cortisol within interventional studies, and lit-
tle is known about how salivary cortisol has been employed,
to date, as a biomarker within RCTs of health and behavioural
interventions. The inherent complexity of salivary diurnal cor-
tisol as a biomarker is likely to pose particular challenges
within RCTs. Given that the diurnal profile is essentially a
composite of at least three measurement parameters (the cor-
tisol awakening response, diurnal slope and area under the
curve), each reflecting different aspects of HPA axis function,
it is possible that experimental interventions will have differ-
ent effects on different parameters. This is likely to impact on
a priori decisions about the primary measurement parameter
of interest, on hypotheses about directions of change and on
conclusions about efficacy, target engagement and mecha-
nisms of action. As well as these challenges, there are con-
cerns in the literature about the long-term stability of this
biomarker over periods of greater than 1 month [17], as well
as concerns about its reliability in the shorter term due to day-
to-day state effects [18] and the effects of non-compliance
[19]. Concerns have also been raised about the responsiveness
of the biomarker and how different contexts and populations
may impact on this [20].
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To assess whether specific guidance is necessary, we sys-
tematically reviewed the literature with the aim of describing
the RCTs of health and behavioural interventions which have
used salivary diurnal cortisol as an outcome measure, partic-
ularly focusing on salivary diurnal cortisol methodology and
findings. Specifically, we aimed to explore the following
questions:
1. Which health and behavioural interventions have been
evaluated using salivary diurnal cortisol?
2. What populations have been evaluated?
3. What collection protocols have been used to obtain a di-
urnal cortisol profile?
4. What parameters of the diurnal cortisol profile have been
measured?
5. Where a change in a cortisol profile parameter is ob-
served, when in the follow-up period does it occur?
6. How often is there consistency between the clinical and
cortisol response to the intervention?
Methods
The protocol for this review is available in the Electronic
Supplementary Material 1.
Study Inclusion and Exclusion Criteria
We restricted the sample to RCTs only. Though the review
question is relevant to non-randomised uncontrolled longitu-
dinal studies also, we chose to select RCTs only in order to
reduce the scope of the search and the heterogeneity of the
sample; this was deemed necessary given the broad review
question with respect to interventions and sample populations.
We also expected that RCTs would be of higher quality than
other study designs, thus providing more reliable information.
We defined ‘diurnal cortisol profile measurement’ as the col-
lection of at least two samples of salivary cortisol over at least
1 day. This would enable the calculation of the diurnal slope or
the cortisol awakening response, at minimum.Within the con-
text of an RCT, there needed to be evidence that this measure-
ment had been obtained on at least one occasion before the
intervention and on at least one separate occasion (i.e. a sep-
arate day or period of days) after the intervention. Using these
definitions, we adhered to the following inclusion and exclu-
sion criteria:
Inclusion Criteria
1. Population: any adult (>18 years) population.
2. Study design: randomised controlled trials.
3. Interventions: any type of therapeutic intervention de-
signed to improve an aspect of health or well-being, ex-
cluding exogenous corticosteroids.
4. Control or comparator: any type of control or comparator.
5. Outcome measures: studies that use salivary diurnal cor-
tisol profile measurement as a primary or secondary out-
come measure.
Exclusion Criteria
1. Non-RCT studies, including quasi-randomised con-
trolled trials and trial protocol reports without results
2. Studies which use non-diurnal salivary sampling
methods e.g. single salivary cortisol measures pre and
post an intervention or salivary cortisol pre and post a
stress-task
3. Studies which evaluate the effects of exogenous gluco-
corticoids (any type or route) on salivary cortisol
4. Studies which evaluate the cortisol response to stress-
inducing interventions or conditions
5. Studies which measure diurnal cortisol under laboratory-
induced conditions (e.g. light-wake conditions)
6. Studies in which the diurnal profile is not measured both
before and after the intervention
7. Studies in which the diurnal profile is obtained on the
same day as the intervention with a view to assessing its
acute effects within the day
8. Studies in people with Cushing’s disease
9. Animal studies
10. Abstract publication available only
11. Dissertation or non-journal publication available only
12. Non-English language publications
Search Methods for Identification of Studies
On 21 May 2015, we searched the following electronic data-
bases using NHS Evidence Healthcare Databases Advanced
Search tool: MEDLINE (1980 to May 2015), CINAHL (1980
to May 2015), PsychINFO (1806 to May 2015), AMED
(1985 to May 2015), EMBASE (1974 to May 2015) and the
Cochrane Central Register of Controlled Trials. We sought to
identify a combination of keywords and MESH terms in the
titles and abstracts of papers, adapting the search strategy, as
appropriate, for each database. By way of example, the fol-
lowing keywords, MESH terms and publication types were
searched in MEDLINE: [(‘cortisol’ AND ‘saliva*’) OR (HY-
DROCORTISONE/ AND SALIVA/)] AND [(‘randomized
controlled trial’ OR ‘controlled clinical trial’ OR ‘random-
ized’ OR ‘placebo’ OR ‘randomly’ or ‘trial’ OR ‘groups’,
excluding ANIMALS (exploded term)]. See Appendix A for
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more detailed search strategies, including strategies used in
the other databases.
Study Selection for Inclusion in the Review
All abstracts generated from the electronic searches were
exported to Endnote X3 for removal of duplicates. One review
author (RR) screened the titles and abstracts for the eligibility
criteria, and where eligibility could not be determined, the
full-text article was obtained. All full-text articles were
reviewed for eligibility by RR, and a random selection of these
articles (37 %) were reviewed independently by the other four
authors (SB, AS, AC and SM), each reviewing a different
selection, to ensure that the eligibility criteria were being cor-
rectly interpreted and adhered to. The inclusion criteria were
applied in a hierarchical manner, first checking the population,
then the study design, then the intervention and finally the
cortisol methodology. Any disagreement was discussed in
the first instance between the two authors in question. If con-
sensus was not achieved between the two authors in question,
a third party (one of the other authors) was consulted.
Data Collection and Extraction
All full-text articles which were deemed eligible were
reviewed in more detail for data extraction. RR completed
the data extraction for all eligible texts. In addition, another
author independently completed data extraction on 10 % of
the eligible articles to ensure that data were being extracted
appropriately. A data extraction form containing the following
fields was used to summarise the pertinent details of the study:
trial ID, eligibility criteria checklist with decision outcome,
study design, population, intervention/control, salivary corti-
sol collection protocol details, other outcome measures, sali-
vary cortisol analysis details, salivary cortisol results and clin-
ical outcome results.
Assessment of Quality and Relevance
The quality of each study and its relevance to the review aim
were assessed using the Gough Weight of Evidence frame-
work [21], which uses four domains of assessment (A, B, C
and D), rating each domain as low, moderate or high. As the
overarching aim of this review was to describe salivary corti-
sol methodology and findings in RCTs, the relevance of each
study was assessed purely in relation to the degree to which it
contributed information towards this aim.
Within the first domain of this framework, judgments are
made in relation to the generic quality of execution of the
study independent of the review aim (Weight of Evidence
A). Within the second and third domains, judgements are
made in relation to the specific aim of the review, including
the appropriateness of the study design to the review aim
(Weight of Evidence B) and the focus of the study, including
its objectives and reporting, relative to the review aim (Weight
of Evidence C). An overall judgement of quality and rele-
vance (low, moderate or high) is formed by combining the
assessments for these domains (Weight of Evidence D). This
framework is weighted more heavily towards relevance than
quality and was chosen as a means of highlighting those stud-
ies which provided the most relevant information towards the
review aim. This was deemed to be the most appropriate ap-
proach to appraising the literature included in this review,
given that we were not concerned with evaluating the efficacy
of specific interventions.
Data Synthesis and Presentation
The selection process is presented using a PRISMA flow
chart. A narrative synthesis of the scope, characteristics and
findings of the selected studies is given and presented in ta-
bles. To enhance clarity and facilitate comparison, individual
studies were organised into four categories according to the
intervention being evaluated, and a separate table of studies
was created for each category. Counts and percentages were
used to describe data patterns across all studies and between
study intervention categories. Medians and interquartile
ranges were calculated to describe key features of the salivary
collection protocol across studies and to describe the frequen-
cy and distribution of the follow-up time-points at which cor-
tisol findings occurred. For a cortisol parameter, a significant
finding was considered to be present if a study reported a
statistically significant within- or between-group effect from
baseline to follow-up, for either the intervention or the com-
parator group. If a significant finding was also reported for at
least one clinical outcome measure in the same study, using
the same statistical tests, the cortisol findings were considered
to support the clinical outcome. In the same way, if there was
no evidence of a statistically significant effect for both the
cortisol and clinical outcomes, cortisol findings were consid-
ered to support clinical findings.
Results
Selection Process
The process of screening and reviewing articles for eligibility
is summarised in Fig. 1. The database search identified 2374
articles. After removal of duplicates using Endnote X3, 1812
potentially relevant abstracts were identified. Screening of
these abstracts led to the selection of 219 full-text articles for
more detailed eligibility assessment. Of these full-text articles,
78 studies were selected for inclusion in the review after re-
moval of ineligible studies and after exclusion of duplicate
reports of the same study. The most common reason for
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exclusion of articles related to salivary cortisol methodology.
After excluding studies due to ineligible populations, inter-
ventions and designs, 87 of the remaining 175 RCTs (50 %)
were excluded because the salivary cortisol measurements
therein did not allow analysis of the diurnal rhythm. In most
cases, this was due to the measurement of cortisol on a single
occasion before and after the intervention being evaluated. A
small number of RCTs (n=10), which did include diurnal
cortisol measurements, were later excluded from the review
because their cortisol findings were not adequately reported or
because their measurements were conducted in a way that was
not comparable with the other studies.
Characteristics of Included Studies
Included studies were published from 2003 to May 2015.
There has been a notable increase in the number of published
RCTs using salivary diurnal cortisol as an outcome measure in
the past decade, with the yearly rate increasing from 2 studies
per year in 2003 and 2004 to 14 studies in 2013 and 11 studies
in 2014 (see Fig. 2). Indeed, over 50 % of the included studies
have been published since 2012. Pertinent characteristics of
individual studies are presented within Tables 1, 2, 3 and 4,
with each table representing one of four study categories and
each study being organised into one of such categories accord-
ing to the intervention being evaluated: (1) RCTs evaluating
psychosocial interventions, (2) RCTs evaluating pharmaco-
logical (including nutritional) interventions, (3) RCTs evalu-
ating complementary therapies and (4) RCTs evaluating all
other types of interventions.
Most commonly, studies evaluated psychosocial interven-
tions (n=33, 42.3 %), such as cognitive behavioural therapy,
mindfulness and psychotherapy (see Table 1). Pharmacologi-
cal therapies, including nutritional therapies, comprised the sec-
ond most common intervention category (n=22, 28.2 %),
within which eight studies evaluated anti-depressant medica-
tions (see Table 2). Complementary therapies were evaluated
in 14 studies (17.9 %), with six of these studies evaluating
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yoga (see Table 3). Nine studies evaluated treatments which
did not fall into the three major categories and were, therefore,
classified as ‘other’ (see Table 4). These treatments included
exercise (n=3), cranial electrostimulation (n=2), a lifestyle
intervention (n=1), dietary restriction (n=1), prayer (n=1)
and light treatment (n=1).
Interventions were evaluated in a wide variety of study
populations. Overall, across all studies, these populations
could be broadly classified as follows: people who were
healthy or at risk of disease (n=30, 38.5 %), patients with
physical or psychosomatic disease (n=27, 34.6 %) and pa-
tients with a psychiatric diagnosis (n=21, 26.9 %). Physical
and psychosomatic disease categories included current or pri-
or cancer (n=14; predominantly breast cancer), cardiovascular
disease or metabolic syndrome (n=3), human immunodefi-
ciency virus (n=3), dementia (n=3), Parkinson’s disease
(n=1), irritable bowel syndrome (n=1), tension headache
(n=1) and fibromyalgia (n=1). Psychiatric pathology in-
cluded depression (n=12), anxiety disorder (n=2), co-
morbid anxiety and depression (n=1), post-traumatic
stress disorder (n=3), adjustment disorder (n=1), bipolar
disorder (n=1) and alcoholism (n=1). Within study cate-
gories, psychosocial intervention studies and pharmaco-
logical studies most commonly evaluated people who
were healthy or at risk of disease (42 and 54.5 % of
psychosocial and pharmacological studies, respectively),
whereas complementary therapy studies most commonly
evaluated patients with physical or psychosomatic disease
(86 % of complementary therapy studies).
Overall, across study categories, the median study sample
size was 55 participants (IQR 34–77), with the smallest study
including only 12 participants [76] and the largest including
379 participants [57]. Median sample size was similar be-
tween study categories: 59 (IQR 34–74) for psychosocial in-
terventions, 51 (IQR 41–76) for pharmacological interven-
tions, 49 (IQR 21–90) for complementary therapies and 59
(IQR 24–87) for other interventions. Eight studies were re-
ported as pilot, feasibility or exploratory studies. Overall, the
median length of follow-up from baseline was 10 weeks (IQR
4 to 21) and ranged from 1 to 72 weeks.
Quality and relevance (aggregate score) were rated as high
for 20 studies and moderate for 58 studies. No study was
given an aggregate score of low, reflecting the exclusion of
studies of low relevance by the eligibility criteria. Of note,
many studies were of low quality with respect to their RCT
design but of high relevance with respect to the review aim,
resulting in a high overall aggregate score using Gough’s
framework [21]. See Appendix B for the breakdown of scores
per domain for each included study.
Salivary Cortisol Collection and Analysis Methodology
Pertinent details relating to the salivary cortisol collection pro-
tocols and parameters used in individual studies are presented
in Tables 1, 2, 3 and 4.
In relation to saliva collection, the median number of days of
saliva collection per time-point across studies was 1 day (IQR1–
2). As the median suggests, the majority of studies (n=57,
Fig. 2 Number of eligible RCTs
published per year. The year 2015
was excluded from this graph as
the complete results for this year
are not yet available
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Table 1 Randomised controlled trials evaluating psychosocial interventions: study characteristics, salivary cortisol methodology and main findings
Study ID Main study objective(s) Study 
Populationc
Intervention Comparator 
or Control 
Main outcome 
measures 
Assess-
ment 
period  
Saliva 
collection 
protocola 
Diurnal cortisol 
parameters 
analysedd 
Main cortisol findings Main clinical  
findings 
Quality/ 
Relevance 
b 
Bergen-
Cico et 
al. 2014 
(22) 
To assess the efficacy of 
a brief primary care 
mindfulness programme 
in military veterans with 
post-traumatic stress 
disorder (PTSD) by 
examining changes in 
cortisol as a biomarker.  
40 military 
veterans 
Primary-care-
based brief 
mindfulness-based 
stress reduction 
programme 
(PCbMP) 
delivered in 
weekly 90 min 
sessions over 4 
wks. Home 
practice 
encouraged.  
Primary Care 
treatment as 
usual; they were 
given the option 
of receiving 
PCbMP after 12 
wks. 
1) Salivary 
cortisol 
2) Psychometric 
measures for 
depression and 
PTSD.  
4 wks 2 day 
5 sample points 
(on awakening, 
45 min after 
awakening and 
3 other points) 
1) Total AUC with 
respect to ground 
(AUCg) 
2) AUC with respect 
to increase (AUCi) 
3) CAR calculated 
as the AUC from 
awakening to 45 
min 
There was a significant 
group x time interaction 
effect on AUCi, with 
AUCi decreasing in the 
intervention group and 
increasing in the control 
group over time.  
Pre-post within group 
analysis indicated that the 
CAR reduced significantly 
in the intervention group 
but not in the control 
group.  
There was a 
significant negative 
correlation between 
changes in AUCi and 
changes in depression 
score over time for the 
group as a whole but 
no correlation between 
the changes in cortisol 
and psychometric 
variables when each 
group was analysed 
separately.  
High 
Bormann 
et al. 
2009 (23)  
To determine the effect of 
a spiritually-based 
mantram intervention, in 
comparison with a 
control, on average daily 
salivary cortisol levels in 
HIV-infected adults.  
71 HIV 
infected 
adults 
Spiritually-based 
mantram 
intervention, 
delivered over 5 
weeks in the form 
of face-to-face 
classes 
Attention-based 
control 
intervention 
delivered in the 
format 
1) Spiritual 
wellbeing scale, 
with 
faith/assurance 
subscale as a 
primary outcome 
2) Salivary cortisol 
10 wks 1 day 
4 sample points 
(7am, 11am, 4 
pm, and 9pm) 
Mean diurnal 
cortisol level 
There was no significant 
difference in mean daily 
cortisol level between 
groups at 5 and 10 weeks 
Faith/assurance levels 
were significantly 
higher in the 
intervention group in 
comparison with the 
control group at 5 and 
10 weeks  
Moderate 
Bougea 
et al.
2013 (24)  
To evaluate whether 
emotional freedom 
technique affects the 
frequency and intensity of 
headaches in adults 
suffering from tension-
type headaches 
35 adults 
suffering 
from frequent 
tension-type 
headaches 
Emotional 
freedom technique 
practised twice 
daily over 8 
weeks 
Standard care 
(continued use 
of medication) 
1) Frequency and 
intensity of 
headaches 
2) Perceived stress 
3) Global health 
and health control 
measures 
4) Sleep 
parameters 
5) Salivary cortisol 
8 wks 1 day 
2 sample points 
(8am and 8pm) 
Time-specific 
cortisol level  
There were no significant 
differences in cortisol 
levels (8am or 8pm) 
between the intervention 
and control groups at 8 
weeks 
Headache frequency 
and intensity, and 
perceived stress, were 
significantly lower in 
the intervention group 
in comparison with the 
control at 8 weeks 
Moderate 
Carlson 
et al.  
2013 (25) 
To compare the efficacy 
of mindfulness-based 
cancer recovery (MBCR) 
and supportive-expressive 
group therapy (SET) in 
distressed survivors of 
breast cancer 
271 distressed 
survivors of 
stage 1-III 
breast cancer 
MBCR delivered 
in 90 min weekly 
group sessions 
over 8 wks plus a 
6-hour workshop 
between weeks 6 
and 7 
SET delivered 
in 90 min 
weekly sessions 
over 12 wks 
OR 
Control 
condition: 1-day 
(6-hour) 
didactic stress 
management 
1) Self-reported 
mood (primary) 
2) Salivary 
cortisol  (primary) 
3) Self-reported 
stress 
4) Quality of life 
5) Self reported 
social support 
Up to 
12 wks  
3 days 
4 sample points 
(On awakening, 
noon, 5pm, 
bedtime)  
1) Diurnal slope 
2) Time-specific 
cortisol level  
There was a significant 
group x time interaction 
effect for diurnal slope, 
with slopes becoming 
steeper after SET and 
MBCR, compared with the 
control (SMS). In the 
within-group pre-post 
analysis, there was no 
significant change in slope 
in either MBCR or SET, 
however, but the slope 
There were significant 
group x time 
interaction effects for 
mood and stress in the 
intention to treat 
analysis. Follow-up 
pair-wise comparisons 
for each group 
indicated no 
significant differences 
between the groups for 
mood disturbance, 
High 
seminar (SMS)  became significantly flatter 
in the control (SMS).  
There was a significant 
difference in the change in 
bedtime cortisol between 
the MBCR group and the 
control group, with an 
increase in the SMS group 
and a slight decrease in the 
MBCR group.  
however. Stress 
symptoms, however, 
reduced significantly 
in the MBCR group in 
comparison with both 
the SET and the SMS 
groups.  
Cash et 
al. 2015 
(26) 
To evaluate the effects of 
mindfulness-based stress 
reduction (MBSR) on 
symptoms and 
neuroendocrine function 
in fibromyalgia  
91 females 
with 
fibromyalgia 
MBSR delivered 
in weekly 2.5hour 
sessions over 8 
wks 
Waiting list 
group x 8 wks 
1) Perceived stress 
2) Pain 
3) Sleep quality 
4) Fatigue 
5) Fibromyalgia 
impact scale 
6) Salivary 
cortisol 
16 wks 2 days 
6 sample points 
(On awakening, 
45 min after 
awakening, 
noon, 4pm, 
8pm, bedtime) 
1) Diurnal slope 
(excluding +45min 
sample) 
2) Mean waking 
level 
3) CAR-calculated 
as the mean percent 
increase from 
waking to +45 min 
4) CAR slope 
There were no significant 
differences between the 
two groups at 8 wks or 16 
wks for any of the cortisol 
parameters, controlling for 
baseline values.  
There were significant 
reductions in 
perceived stress, sleep 
problems, fatigue and 
symptom severity in 
the MBSR group 
relative to the control 
at 8 wks, but not in 
pain or physical 
functioning. The 
effects on fatigue were 
not maintained at 16 
wks.  
High 
Chan et 
al. 2006 
(27) 
To investigate the 
psychophysiological 
effects of different 
psychosocial intervention 
methods for breast cancer 
patients 
76 patients 
with breast 
cancer (stage 
I-III) 
Body-mind-soul 
intervention 
OR 
Supportive 
expressive therapy 
OR 
Social support  
Non-
intervention 
control  
1) Psychological 
measures 
including stress 
2) Salivary cortisol 
32 wks 2 days 
5 sample points 
(On awakening, 
45 min after 
awakening, 
12pm, 5pm and 
9pm) 
1) AUC 
2) Diurnal slope 
There was a significant 
reduction in cortisol AUC 
in the body-mind-soul 
group, but not the other 
groups, at 8 months 
There was a 
significant 
improvement in a 
range of psychological 
measures in the body-
mind-soul group only. 
Moderate 
Delle 
Chiaie et 
al. 2012 
(28) 
To investigate if group 
psychoeducation 
normalizes HPA axis 
function in patients with 
bipolar disorder 
(preliminary results of an 
ongoing investigation) 
20 patients 
with 
stabilized 
bipolar 
disorder 
Group psycho-
education 
delivered in 21 
sessions.  
Continuation of 
treatment as 
usual (TAU) 
along with 21 
weekly group 
meetings in 
which no 
special 
instruction was 
given 
1) Depression 
2) Mania 
3) Compliance 
with drug 
treatment 
4) Salivary 
cortisol 
20 wks 1 day 
5 sample points 
(08.00am, 30 
min and 60 min 
after, 1pm, 
8pm) 
The first 3 sample 
points (representing 
the CAR) and the 
last 2 sample points 
(diurnal decline) 
were analysed in 
separate ANOVA 
models at each 
timepoint, with  
sample time as the 
within group factor 
and treatment as the 
between group 
factor.  
There were no significant 
differences between groups 
at baseline. After 
treatment, there was a 
significant difference 
between groups in the 
morning pattern of cortisol 
secretion (CAR), with an 
increase in the CAR in the 
psychoeducation group.  
There were no 
significant changes in 
the clinical measures  
Moderate 
Gaab et 
al. 2006 
(30)  
To evaluate the effects of 
cognitive behavioural 
stress management 
(CBSM) on psychological 
and somatic wellbeing 
and neuroendocrine 
responses in students 
preparing for an academic 
exam.  
28 healthy 
economics 
students 
Cognitive 
behavioural stress 
management 
programme over 4 
weeks 
Waiting list 
control 
1) Psychological 
measures 
including anxiety, 
stress and 
depression 
2) Somatic 
symptoms 
3) Salivary cortisol 
4 wks 1 day 
9 sample points 
(On awakening, 
15, 30, 45 and 
60 min 
AND 
8am, 11am, 
3pm and 8pm) 
1) CAR measured by 
AUC over the first 
hour 
2) Total AUC over 
full day 
There was a significant 
time x group interaction 
effect for the CAR, with a 
significant change in the 
CAR in the intervention 
group 
There was a 
significant time x 
group interaction 
effect on anxiety and 
somatic symptoms, 
with less anxiety and 
somatic symptoms in 
the intervention group. 
High 
Feicht et 
al. 2013 
(29) 
To explore whether 
‘happiness training’ 
improves individual 
happiness and satisfaction 
with life and relieves 
stress in an occupational 
setting.  
147 adult 
volunteers 
working in an 
insurance 
company 
Web-based 
happiness training 
for 7 wks 
Waiting list 
group  
1) Happiness and 
satisfaction with 
life on a visual 
analogue scale 
2) Wellbeing 
3) Stress warning 
signals 
4) Mindfulness 
5) Recovery 
experience 
6) Flourishing  
7) Salivary 
cortisol and alpha-
amylase 
(subsample only- 
n=45) 
8) Attention 
network test 
11 wks 1 day 
3 sample points 
(on awakening, 
30 min later, 
8pm) 
1) CAR: 30 min 
sample minus 
awakening sample 
2) ‘Morning 
activity’: mean of 30 
min sample plus 
awakening sample 
3) ‘Evening 
activity’: 8pm level 
4) Circadian 
amplitude: evening 
sample minus 
awakening sample 
There were no significant 
within or between group 
differences for any of the 
cortisol parameters 
There were significant 
within and between 
group changes for a 
range of psychological 
measures, with 
evidence of increased 
happiness and 
satisfaction in life and 
reduced stress in the 
intervention group.  
Moderate 
ann. behav. med.
Table 1 (continued)
Gex-
Fabry et 
al. 2012 
(31) 
1) To confirm the 
efficacy of mindfulness-
based cognitive therapy 
(MBCT) compared with 
Treatment as Usual 
(TAU) in reducing 
relapse risk in patients in 
remission from recurrent 
depression 
2) To examine possible 
changes in diurnal 
salivary cortisol profiles 
over the follow-up period 
60 adult 
patients in 
remission 
from 
recurrent (≥3 
episodes) 
depression, 
off anti-
depressant 
medication 
for at least 3 
months 
MBCT plus TAU 
MBCT was 
delivered in 8 
weekly sessions 
over 2 months 
TAU 
Any care 
deemed 
necessary 
1) Rate of relapse 
of depression 
2) Time to relapse 
of depression 
3) Salivary 
cortisol 
56 wks 1 day 
7 sample points 
(On awakening, 
followed by 15, 
30, 45 and 60 
min post-
awakening, and 
at 3pm and 
8pm) 
1) CAR: AUC 
above the minimum 
concentration in the 
first hour after 
awakening 
2) Diurnal Slope: 
difference between 
wake-up and last 
evening values, 
divided by the time 
interval between 
these samples 
3) Total AUC 
There were no significant 
time x group effects for 
any cortisol parameter 
measured, indicating that 
there was no significant 
difference between groups 
at any follow-up point in 
relation to cortisol 
There was no 
significant difference 
in depression relapse 
rate between the two 
groups over the 
follow-up period 
High 
Holt-
Lunstad 
et al. 
2008 (32)  
To test the hypothesis that 
couple-based emotional 
support training that 
enhances warm physical 
contact between marital 
partners may induce 
increases in oxytocin 
34 healthy 
married 
couples 
‘’Warm Touch” 
Support 
Enhancement 
Intervention- 
training provided 
over 4 weeks 
Couples were 
advised to keep 
a diary of 
physical 
affection and 
mood over 4 
weeks 
1) Ambulatory 
blood pressure 
2) Plasma and 
salivary oxytocin 
3) Salivary 
cortisol 
4) Salivary alpha-
4 wks 1 day 
5 sample points 
(On awakening, 
7am, 12pm, 
5pm, 10pm) 
AUC Mixed model analysis  
indicated that there was no 
main effect of the 
intervention on salivary 
cortisol AUC 
The intervention had a 
significant effect on 
salivary oxytocin and 
alpha amylase levels 
but no significant 
effect on plasma 
oxytocin levels or 
Moderate 
activity and decreases in 
stress hormones and 
blood pressure.  
amylase ambulatory blood 
pressure.  
Hsiao et 
al. 2011 
(33) 
To examine the 
psychobiological effects 
of psychotherapy coupled 
with pharmacotherapy 
versus pharmacotherapy 
alone in patients with 
major depressive disorder 
63 adults (18-
65 years) 
with major 
depressive 
disorder 
attending an 
outpatient 
psychiatry 
clinic 
Combined therapy 
(COMB): mind-
body-spirit 
psychotherapy 
delivered over 8 
weeks in addition 
to 
pharmacotherapy 
Monotherapy 
(MT): 
pharmacotherap
y alone 
1) Depression 
scale 
2) Anxiety scale 
3) Salivary 
cortisol  
32 wks 1 day 
5 sample points 
(On waking, 45 
min after 
waking, 12 
noon, 5pm, 
9pm) 
1) Time-specific 
cortisol level 
2) Diurnal pattern- 
modelled using 
mixed modelling 
techniques 
Mixed model analysis 
indicated that there was no 
significant time x group 
interaction effect on 
second-order polynomial 
diurnal cortisol change 
pattern (planned analysis) 
but there was a significant 
time x group interaction 
effect on first-order 
polynomial diurnal cortisol 
change pattern (post-hoc 
analysis).   
Analysis of the change in 
cortisol slope from 
baseline to each follow-up 
timepoint indicated that the 
change in the cortisol slope 
over the 3 follow-up points 
differed significantly 
between COMB and MT, 
with the slope becoming 
steeper in the COMB 
group.  
There were no time x 
group interaction 
effects or time main 
effects on depression 
scores or state anxiety 
scores. However, there 
was a group main 
effect in change in 
anxiety scores, with a 
greater change 
observed in the 
COMB group.  
Moderate 
Hsiao et 
al. 2012 
(34)  
To understand the effect 
of a body-mind-spirit 
intervention on 
depression state, sense of 
meaning in life, and 
diurnal cortisol patterns 
in breast cancer survivors 
48 breast 
cancer 
survivors 
attending a 
surgical 
outpatient 
department 
Body-mind-spirit 
group therapy 
delivered for 2 
hours weekly over 
2 months 
Educational 
session 
delivered as 1 
session 
1) Depression 
state measure 
2) Meaning in life 
measure 
3) Salivary 
cortisol 
32 wks 1 day 
6 sample points 
(On awakening, 
30 min, 45 min, 
12 noon, 5pm, 
9pm) 
1) Diurnal decline: 
calculated based on  
regression of the 6 
cortisol levels 
2) Time-specific 
cortisol level 
The control group 
developed a  significantly 
higher 21.00 cortisol level 
and a flatter slope, in 
comparison with the 
intervention, over the 8 
month follow-up period 
There were no 
significant differences 
between groups over 
time in relation to the 
depression scores and 
the ‘Meaning-in-life 
Questionnaire-
Presence scores’. 
However, there was a 
significant difference 
between groups in the 
‘Meaning in Life 
Questionnaire- Search 
scores’ over 5 months 
(but not 8 months) 
Moderate 
Jensen et 
al. 2012 
(36)  
To test the effects of 
mindfulness-based stress 
reduction (MBSR) on 
attention in healthy 
volunteers 
48 healthy 
volunteers 
who were 
meditation 
novices, 
recruited 
from a 
university.  
Mindfulness-
based stress 
reduction 
(MBSR), 
delivered once 
weekly in 2.5 hour 
sessions, over 8 
wks. It also 
included home 
assignments and 
an intensive 
retreat.  
Non-
mindfulness-
based stress 
reduction 
(NMSR): 
resembled 
MBSR but did 
not include 
meditation 
practices nor 
training in a 
non-judgmental 
attitude 
OR 
Non-treatment 
inactive control 
1) 5 attentional 
tasks 
2) Salivary 
cortisol 
3) Perceived stress 
4) Mindfulness 
and awareness 
8 wks 1 day 
5 sample points 
(on awakening, 
15min,30min, 
45min and 60 
min after 
awakening) 
1) CAR AUCg: area 
under the curve with 
respect to ground, 
reflecting magnitude 
2) CAR AUCi: area 
under the curve with 
respect to increase, 
reflecting pattern 
There was a significant 
within-group reduction in 
AUCi in the MBSR group 
with no significant within-
group changes in the other 
groups.  
There was a group x time 
interaction effect for 
AUCg when MBSR was 
compared to the control but 
not when MBSR was 
compared with NMSR.  
There was a 
significant 
improvement in 
mindfulness and 
perceived stress in the 
MBSR group, with no 
significant change in 
the other groups.  
There was a group x 
time interaction effect 
for these measures 
when MBSR was 
compared to the 
control but not when 
MBSR was compared 
to NMSR.  
Attentional measures 
not relevant to this 
review. 
Moderate 
Klatt et 
al. 2009 
(37) 
To determine whether 
low-dose mindfulness-
based stress reduction 
(MBSR-ld) significantly 
decreases symptoms of 
stress and to yield 
adherence rates similar to 
those for traditional 
MBSR interventions 
48 healthy 
university 
staff members 
aged 18-60 
years 
MBSR-ld 
delivered over 6 
weeks 
Waiting list 
control over 6 
weeks 
1) Perceived stress 
2) Sleep  
3) Level of 
mindfulness 
4) Salivary 
Cortisol 
6 wks 2 days 
3 sample points 
(20 min after 
waking, 1pm 
and 10pm) 
Mean diurnal 
cortisol level 
There was no significant 
change in cortisol levels 
over time in either group.  
There was a 
significant 
improvement in 
mindfulness and 
perceived stress in the 
intervention group, but 
not in the control 
group. 
Moderate 
Hsiao et 
al. 2014 
(35) 
To examine the effects of 
psychotherapy on 
depressive and anxiety 
symptoms, suicidal 
ideation and diurnal 
71 patients 
with 
adjustment 
disorder 
associated 
Body-mind-spirit 
(BMS) 
psychotherapy 
received in 
addition to 
Control: similar 
to treatment as 
usual which 
includes 
medication and 
1) Depression 
2) Anxiety 
3) Occurrence of 
suicidal ideation 
4) Salivary 
56 wks 1 day 
6 sample points 
(on awakening, 
30 min after,  
Diurnal slope 
calculated by 
regressing cortisol 
values at all 6 
sample points 
There was a significant 
group x time interaction 
effect for diurnal slope, 
with a significantly steeper 
slope at 56 wks and a trend 
There were no 
significant group x 
time interaction effects 
for depression and 
anxiety, with similar 
Moderate  
cortisol patterns in 
patients with adjustment 
disorder and depressed 
mood.  
with 
depressed 
mood, 
recruited 
from a 
psychiatric 
outpatient 
clinic  
treatment as usual. 
This was 
delivered in 8 
wkly group 
sessions. 
psycho-
education 
cortisol 45 min after, 
12.00, 17.00, 
21.00) 
against time towards a steeper slope at 8 
wks in the intervention 
(BMS) group compared to 
the control group.  
reductions in both 
groups. There was no 
group x time 
interaction effect for 
the occurrence of 
suicidal ideation but 
there was a trend 
toward a greater 
decrease in occurrence 
of suicidal ideation in 
the BMS group 
compared with the 
control.  
Krajewsk
i et al. 
2011 (36) 
To explore the impact of 
different ways of 
spending lunch-time 
breaks on cortisol.  
14 call centre 
employees 
Progressive 
muscle relaxation 
(PMR) performed 
by the participant 
for 20 min during 
Small-talk (ST) 
for 20 min, with 
self-chosen 
colleagues in 
the staff room, 
Salivary cortisol 24 wks 1 day 
5 sample points 
(On awakening, 
30 min after, 
1) CAR (delta): 30 
min sample minus 
awakening sample 
2) CAR (mean): 
mean of awakening 
There was a significant 
group x time interaction 
effect for CARdelta and 
bedtime cortisol, with a 
reduction in the PMR 
N/A Moderate 
lunch-break in a 
‘silent room’ over 
a 6-month period.   
over a period of 
6 months.  
11.55, 13.05, 
bedtime) 
11.55 and 13.05 
samples were 
done pre and 
post the 
intervention to 
assess its 
immediate 
effects 
plus 30 min sample 
3) Pre-post 
intervention cortisol 
effect: 13.05 sample 
minus 11.55 sample 
4) Bedtime cortisol: 
to assess ‘spillover’ 
effects  
Cortisol assessment 
over 8 timepoints 
group relative to the ST 
group. For CAR, the 
change occurred towards 
the end of the 6 month 
period whereas there was a 
short-term and long-term 
effect on bedtime cortisol. 
Pre-posts acute changes 
not relevant to this review  
ann. behav. med.
Table 1 (continued)
Letour-
neau et 
al. 2011 
(39) 
To evaluate the effect of a 
home-based peer support 
intervention, that 
included maternal –infant 
interaction teaching, on 
mother-infant interactions 
and other secondary 
measures 
(Infant measures not 
reported in this review as 
not relevant) 
60 mother-
infant dyads 
in which the 
mother had a 
diagnosis of  
post-partum 
depression < 
9 months 
after delivery 
Peer support from 
a local volunteer, 
which included 
teaching on 
maternal-infant 
interaction 
techniques x 12 
weeks 
Waiting list 
group x 12 
weeks (received 
peer support 
after 12 weeks) 
1) Mother-infant 
interaction 
(primary) 
2) Maternal 
depressive 
symptoms 
3) Maternal 
perception of 
social support 
4) Maternal 
salivary cortisol 
5) Infant measures 
(not addressed 
here) 
12 wks 1 day 
4 sample points  
(On awakening, 
noon, mid-
afternoon, 
before bed) 
AUC There were no significant 
time or treatment effects on 
maternal cortisol AUC.  
There was a 
significant difference 
between groups in 
maternal-infant 
teaching interactions, 
favouring the control. 
Depressive symptoms 
improved significantly 
over time in both 
groups.  
Moderate 
Limm et 
al. 2011 
(40) 
To test the long-term 
effect of a stress-
management intervention 
on self-perceived stress 
reactivity in employees 
174 lower 
and middle 
management 
employees in 
an 
international 
plant 
Stress 
management 
intervention 
delivered over 2 
full days, with 
booster sessions 
over the following 
8 months 
Waiting-list 
group x 1 year 
1) Perceived stress 
reactivity  
2) Effort-reward 
imbalance 
measure 
3) Anxiety and 
depression 
measures 
4) Salivary 
cortisol 
5) Salivary α-
amylase 
1 year 1 day 
7 sample points 
(On awakening, 
30 min, 60 min, 
8am, 11am, 
3pm, 8pm) 
1) CAR measured in 
two ways:  
a) by subtracting the 
‘awakening level’ 
from the 30min 
level and b) by 
calculating the AUC 
for the morning 
values 
2) Diurnal decline 
slope measured by 
linear regression  
3) AUC using all 
timepoints 
There were no significant 
findings for the salivary 
cortisol parameters 
There was a 
significant 
improvement in self-
perceived stress 
reactivity in the 
intervention group 
compared with the 
control 
High 
Lipschitz 
et al. 
2013 (42) 
To explore whether 
salivary α-amylase (sAA) 
and salivary cortisol 
levels are positively 
modulated by sleep-
focused mind-body 
interventions in cancer 
survivors with sleep 
disturbance 
(pilot) 
Non-biological outcomes 
reported in Nakamura et 
al. 2013 (58) 
57 cancer 
survivors 
with self-
reported sleep 
disturbance 
Mind-Body 
Bridging (MBB) 
classes delivered 
in once wkly 2-
hour sessions over 
3 wks 
OR  
Mindfulness 
Meditation (MM) 
classes delivered 
in once wkly 2-
hour sessions over 
3 wks 
Sleep Hygiene 
Education 
(SHE) classes 
delivered in 
once wkly 2-
hour sessions 
over 3 wks 
1) Salivary 
cortisol 
2) Salivary sAA 
3) Sleep problems 
4) Perceived stress 
5) Quality of life 
3 wks 2 different 
schedules over 
2 days (1 day of 
each schedule) 
4 sample points 
on day 1 
(30min post-
awakening, 
noon, afternoon, 
evening) 
1 sample point 
on day 2 (on 
awakening) 
1) Waking cortisol 
2) AUC: only the 4 
measures from the 
first day included 
2) Post-intervention 
diurnal profile 
modelled using 
mixed-effects 
ANCOVA: only the 
4 measures from the 
first day included, 
with intervention 
and intervention x 
collection time as 
fixed factors 
There were no significant 
group main effects or 
group x collection time 
effects, post- intervention, 
for any of the cortisol 
parameters.  
Mean sleep problems 
score was significantly 
lower in the MBB 
group in comparison 
with the SHE group, 
while MBB and MM 
did not differ, post-
intervention.   
High  
Lok et al. 
2012 (44) 
To investigate whether 
HPA axis activity in 
recurrent depressive 
disorder is influenced by 
cognitive therapy, along 
with other objectives 
relating to an embedded 
case-control study. 
Non-biological outcomes 
and RCT design reported 
in Bockting et al. 2005 
(60) 
187 highly 
recurrent 
major 
depressive 
disorder 
patients 
Cognitive therapy 
delivered in once 
weekly 2-hour 
group sessions 
over 8 wks 
Usual care  1) Depression 
recurrence 
2) Salivary 
cortisol 
3) Other 
secondary self-
report outcomes 
2 years 2 different 
schedules over 
2 days:  
2 sample points 
on Day 1: 8am 
and 8pm 
1 sample point 
on day 2: 8am 
Profile was 
modelled using 
mixed linear 
modelling with 
group, follow-up 
point  and sample 
moment as 
independent 
variables 
There was a borderline 
significant effect of steeper 
cortisol declines over the 
day throughout the follow-
up period.  
Cognitive therapy was 
reported to have had a 
significant protective 
effect on depression 
recurrence over the 2-
year follow-up period 
in Bockting et al. 2005 
(60).   
High 
Nickel C 
et al. 
2007(46) 
& Nickel 
M.K. 
2007 (47) 
To determine the 
effectiveness of 
behavioural/psycho-
educational group 
training in men suffering 
from chronic 
occupational stress 
72 men (≤ 65 
years) who 
self-identified 
themselves as 
suffering 
from chronic 
occupational 
stress  
Behavioural 
psycho-
educational group 
therapy delivered 
in twice weekly 
90 min sessions 
over 8 weeks 
90min group 
meetings twice 
weekly over 8 
weeks, during 
which 
participants 
reported on 
work events 
1) Systolic blood 
pressure 
2) Salivary cortisol 
3) Self-report 
measures of 
chronic stress, 
anger and health-
related quality of 
life 
8 wks 5 days 
4 sample points 
(On awakening, 
15, 30 and 60 
min after 
awakening) 
Time-specific 
cortisol level 
(averaged over 5 
days for each 
collection time) 
There was a significant 
decrease in cortisol level at 
all collection time points in 
the treatment group in 
comparison with the 
control group. 
There was a 
significant 
improvement in 
systolic blood pressure 
and in most of the 
subscales measuring 
chronic stress, anger 
and health-related 
quality of life in the 
intervention group in 
comparison with the 
control group.  
Moderate 
Lindh-
Astrand 
et al. 
2013 (41) 
To study the efficacy of 
group therapy with 
applied relaxation on 
vasomotor symptoms in 
postmenopausal women 
60 healthy 
postmenopau
sal women 
Applied relaxation 
(AR) therapy 
delivered in 10 
group sessions 
over 12 wks 
Non-treatment 
control 
1) Average 
number of 
moderate and 
severe hot flashes 
per 24 hours 
(primary) 
2) Quality of life 
3) Salivary 
cortisol 
24 wks 1 day 
3 sample points 
(On awakening, 
30 min after, 
bedtime) 
Time-specific 
cortisol levels 
‘Morning cortisol’ was 
significantly lower in the 
treatment (AR) group in 
comparison with the 
control at 24 wks but not at 
12 wks 
There was a 
significant decrease in 
number of hot flashes 
in the treatment group 
at 12 and 24 wks in the 
AR group, in 
comparison with the 
control group. There 
was also a significant 
Moderate 
improvement in a 
number of quality of 
life dimensions in the 
AR group relative to 
the control.  
Nunes et To examine the effects of 34 women RVT delivered Usual care 1) Psychological 24 1 day 1) Time-specific There was no significant There was a High 
al. 2007 
(48)  
relaxation and 
visualisation therapy 
(RVT) on psychological 
distress, cortsol levels, 
and immunological 
parameters of breast 
cancer patients 
undergoing radiotherapy 
with stage I 
or II breast 
cancer 
undergoing 
radiotherapy 
daily in group 
sessions over 24 
days, immediately 
after radiotherapy 
distress including 
self-report scales 
of stress, anxiety 
and depression 
2) Salivary 
cortisol 
3) Peripheral 
blood 
mononuclear cells 
days 
3 sample points 
(8am, 12 noon, 
8pm) 
cortisol level 
2) Total AUC 
change in cortisol 
parameters in either the 
intervention or control 
group 
significant reduction in 
stress, anxiety and 
depression scores in 
the intervention group 
Oken et 
al. 2010 
(49) 
To evaluate whether a 
mindfulness meditation 
intervention might be 
effective in caregivers of 
close relatives with 
dementia  and to help 
refine the protocol for 
future trials 
(pilot study) 
31 healthy 
adults caring 
for a close 
relative with 
dementia  
Mindfulness-
based cognitive 
therapy (MBCT): 
delivered in once 
wkly 90 min 
sessions delivered 
over 6 wks 
Dementia 
education 
classes: 
matched with 
the mindfulness
meditation
intervention in
relation to time, 
social support, 
discussion time 
and home 
assignments 
OR 
Respite-only 
intervention: 3 
hours wkly for 
7 wks 
1) Perceived stress 
(revised memory 
and behaviour 
problems 
checklist) 
2) Salivary 
cortisol 
3) Several 
exploratory 
secondary 
measures 
7 wks 1 day 
3 sample points 
(On awakening, 
30 min after 
awakening, 
bedtime) 
Time-specific 
cortisol levels: each 
collection point 
analysed separately 
There were no significant 
differences between groups 
for any of the cortisol 
measures post-intervention 
Perceived stress was 
significantly lower in 
the MBCT and 
education groups in 
comparison to the 
respite group post-
intervention 
Moderate 
Pacella et 
al. 2014 
(50) 
To examine the impact of 
successful PTSD 
treatment on the cortisol 
awakening response 
(CAR) 
29 adults with 
chronic PTST 
(subsample 
from larger 
RCT) 
Psychotherapy 
delivered in once 
weekly 90-120 
min sessions over 
10 wks 
Sertraline 
titrated upwards 
as indicated, 
monitored by a 
psychiatrist 
1) PTSD 
symptoms 
2) Depression 
3) Salivary 
cortisol 
10 wks 1 day 
4 sample points 
(on awakening, 
30, 45 and 60 
min after 
awakening)  
CAR: measured by 
AUCg and AUCi 
Changes in CAR AUC did 
not differ between groups. 
CAR AUCi or AUCg were 
not predicted by clinical 
response to treatment in a 
regression analysis.   
23 out of the 29 
participants responded 
to either 
psychotherapy or 
sertraline in relation to 
PTSD symptoms.  
Moderate 
ann. behav. med.
Table 1 (continued)
Sears et 
al. 2007 
(54) 
To investigate whether an 
ICD (implantable 
cardioverter defibrillator) 
shock and stress 
management program 
reduces psychological 
and physiological 
markers of anxiety and 
increases quality of life in 
patients with ICDs 
30 adult 
patients with 
ICDs and a 
history of at 
least one 
shock in the 
previous year  
Cognitive 
Behavioural 
therapy focused 
on shock and 
stress 
management 
delivered over 6 
weeks  
1-day psycho-
educational 
workshop 
1) Psychological 
measures of 
anxiety and 
depression 
2) Quality of life 
3) Device 
acceptance 
4) Salivary 
cortisol 
5) Inflammatory 
markers 
4 wks 
for 
cortisol 
1 day 
6 sample points 
(times not 
reported) 
Mean diurnal 
cortisol level 
There was a significant 
reduction in mean cortisol 
in the overall sample 
(n=30). However, there 
was no time x group 
interaction effect in 
relation to mean diurnal 
cortisol level  
There was a 
significant 
improvement in 
anxiety, depression 
and quality of life in 
the overall sample and 
improvements in 
anxiety and mental 
quality of life were 
significantly greater 
the CBT group 
Moderate 
Taylor et 
al. 2009 
(55) 
To determine the effects 
of improving depression 
in depressed older 
patients with elevated 
cardiovascular risk 
48 older 
adults (≥55 
years) with 
depression 
and elevated 
cardiac risk 
Cognitive 
behavioural 
therapy (at least 
10 sessions) 
Waiting list 
control  
1) Depression 
measures 
2) Cardiovascular 
risk factor 
measurement 
3) Salivary 
cortisol 
24 wks 2 days 
5 sample points 
(On awakening, 
30 min after 
awakening, 12 
noon, 5pm, 
9pm) 
1) Diurnal slope 
2) Waking cortisol 
3) CAR (referred to 
as the ‘cortisol rise 
after waking’- no 
details on 
calculation) 
There was no significant 
difference between groups 
in relation to cortisol 
parameters at 6 months 
There was a 
significant 
improvement in mood 
in the intervention 
group in comparison 
with the control at 6 
months 
High 
Urizar 
and 
Munoz, 
2011(56)  
To determine whether 
participation in a prenatal 
cognitive behavioural 
stress management 
programme would result 
in lower cortisol and self-
reported stress, relative to 
the control, in women at 
high risk for depression 
during pregnancy 
Infant measures not 
reported here as not 
relevant to the review 
57 pregnant 
(6-28 weeks 
gestation) 
women at 
high risk for 
depression  
Cognitive 
behavioural stress 
management 
programme 
delivered over 12 
weeks, with 4 
booster sessions in 
the post-partum 
period 
Usual care 1) Salivary 
cortisol 
2) Perceived stress 
3) Maternal mood 
72 wks 1 day 
2 sample points 
(Morning and 
evening) 
1) Morning cortisol  
2) Evening cortisol  
3) Mean diurnal 
cortisol level 
4) Diurnal decline: 
difference between 
morning and 
evening cortisol 
values 
The mean cortisol level at 
18 months was 
significantly lower in the 
intervention group in 
comparison with the 
control but there were no 
significant differences at 6 
months 
Women in the 
intervention group 
experienced 
significantly higher 
perceived stress than 
women in the control 
group at 6 months but 
no significant 
difference was found 
at 18 months 
Moderate 
Plag et 
al. 2014 
(51) 
To investigate the effect 
of cognitive behavioural 
therapy, in combination 
with physical activity 
program, on salivary 
cortisol and α-amylase 
levels. 
Psychometric outcomes 
reported in Gaudlitz et al. 
2015 (66) 
59 adults with 
panic disorder 
Cognitive 
behavioural 
therapy (CBT) 
delivered in 90 
min sessions over 
1 month, followed 
by a booster 
session 
 + 
High level 
endurance training 
on a treadmill: 30 
min sessions, 3 
times per week 
CBT delivered 
in the same 
schedule  
+ 
Low level 
exercise: 30 min 
sessions, 3 
times per week 
over 8 wks 
1) Salivary 
cortisol 
2) Salivary α-
amylase 
3) Anxiety 
4) Clinical global 
impression 
28 wks 1 day 
5 sample points 
(08am, 12noon, 
4pm, 8pm, 
10pm) 
AUC There was a significant 
group x time interaction 
effect for AUC in an 
ANCOVA at 7 months, 
with a significantly higher 
AUC in the control (low-
level exercise) group.  
There was a 
significant group x 
time interaction effect 
for the Hamilton 
anxiety scale, with a 
significantly greater 
improvement in the 
high level endurance 
training group at 7 
months.  
Moderate 
over 8 wks 
Both treatments 
ran parallel. 
Richter et 
al. 2012 
(53) 
To examine the effects of 
a cognitive-behavioural 
group intervention on 
perceived stress and 
salivary cortisol levels in 
pregnant women 
161 pregnant 
women (10-
15 weeks 
gestation) 
with 
symptoms of 
stress, anxiety 
or depression 
Cognitive 
behavioural group 
program delivered 
in 8 sessions (time 
period not stated) 
Treatment as 
usual  
1) Salivary cortisol 
2) Psychological 
measures 
including 
perceived stress, 
pregnancy-
specific distress, 
anxiety and 
depression 
Up 
until 3 
months 
post-
partum  
1 day 
5 sample points 
(On awakening, 
30 min after 
awakening, 
11am, 5pm, 
10pm) 
1) CAR 
2) Total AUC 
There was a significant 
time x group interaction for 
CAR at the second time-
point (post-intervention- 
approx. 8 weeks). Within 
group analysis 
demonstrated that there 
was a significant decrease 
in CAR in the intervention 
group but not in the control 
group.  
There were no 
significant between-
group differences for 
the psychological 
measures 
Moderate 
Wilcox et 
al. 2014 
(57) 
Wilcox et al. performed a 
secondary statistical 
analysis of the salivary 
cortisol data collected in 
the Well Elderly 2 
randomised controlled 
trial [Clark et al. (70)]. 
The primary aim of this 
RCT was to assess the 
effectiveness of a lifestyle 
intervention on mental 
and physical wellbeing 
and cognitive functioning 
in older people in a 
community setting.  
460 elderly 
adults aged 
60-95 years.  
Only 379 
participants 
agreed to 
provide saliva 
samples, with 
328 providing 
post-
intervention 
data.  
Lifestyle 
intervention: 
small group 
(2hours weekly) 
and individual 
sessions (1 hour x 
10) led by an 
occupational 
therapist over 6 
months.  
Non-treatment 
control x 6 
months 
(provided with 
the intervention 
upon 
completion of 
the study) 
1) Physical and 
mental wellbeing 
(SF-36) 
2) Depression 
3) Cognitive 
outcome variables 
4) Life 
satisfaction index 
24wks 1 day 
4 sample points 
(On awakening, 
30 min after 
waking, before 
lunch, before 
dinner) 
CAR Two types of statistical 
analysis approaches were 
used.  
1) Conventional approach: 
used mean cortisol and 
mean CAR values 
2) Alternative approach: 
used median cortisol and 
median CAR values 
There was no significant 
change in CAR pre and 
post intervention using 
both approaches. 
The intervention 
significantly improved 
5 wellbeing subscale 
scores as well as 
depression and life 
satisfaction scores.  
Moderate 
Yang et 
al. 2009 
(59) 
To compare the effects of 
combination therapy 
(psychotherapy + 
antidepressant) and 
monotherapy 
(antidepressant alone) on 
salivary cortisol levels in 
outpatients with major 
depression 
65 adults 
attending a 
psychiatric 
outpatient 
clinic with a 
diagnosis of 
major 
depressive 
disorder 
Combination 
therapy 
(psychotherapy + 
antidepressant)  
Psychotherapy 
delivered in 8 
sessions over 2 
months and 
antidepressant 
prescribed for 4 
months lunch-break
in a ‘silent room’
over a 6-month 
period.      
Monotherapy 
(antidepressant 
therapy) x 4 
months over a 
period of 6 
months.
1) Salivary cortisol 
2) Depression 
measure 
16 wks 1 day 
5 sample points  
(On awakening, 
30-45 min post 
awakening, 12 
noon, 5pm, 
9pm) 
1) CAR measured as 
the difference 
between morning 
and 30-45 min value 
2) Diurnal slope 
measured in 2 ways: 
a) difference 
between morning 
and evening values 
b) difference 
between 30-45min 
and evening values 
3) Time-specific 
cortisol levels 
1) There was a significant 
decrease in the 9pm 
cortisol level in the 
combined therapy group in 
comparison with the 
monotherapy group over 4 
months. 
2) There was a significant 
difference in the diurnal 
slope between the two 
groups when measured 
using values from 30-45 
min to evening, with a 
steeper slope in the 
combined therapy group. 
Combined therapy and 
monotherapy both 
resulted in a 
significant 
improvement in 
depression scores, 
with no significant 
difference between 
groups 
Moderate 
11.55, 13.05, 
bedtime) 
11.55 and 13.05 
samples were 
done pre and 
post the 
intervention to 
assess its 
immediate 
effects 
plus 30 min sample 
3) Pre-post 
intervention cortisol 
effect: 13.05 sample 
minus 11.55 sample 
4) Bedtime cortisol: 
to assess ‘spillover’ 
effects  
Cortisol assessment 
over 8 timepoints 
group relative to the ST 
group. For CAR, the 
change occurred towards 
the end of the 6 month 
period whereas there was a 
short-term and long-term 
effect on bedtime cortisol. 
Pre-posts acute changes 
not relevant to this review  
Shaded rows represent studies with agreement between clinical and cortisol findings
aDescribes the number of consecutive days of sampling and the number of samples per day per time-point
bAssessed using Gough’s Framework
cRefers to the number and type of participants randomised
dAbbreviations used for cortisol summary measures: CAR, cortisol awakening response; AUC, area under the curve.
ann. behav. med.
Table 2 Randomised controlled trials evaluating pharmacological (including dietary) interventions: study characteristics, salivary cortisol
methodology and main findings
Study ID Main study objective(s) Study 
Populationc 
Intervention Comparator 
or Control 
Main outcome 
measures 
Assess-
ment 
period  
Saliva 
collection 
protocola 
Diurnal cortisol 
parameters 
analysedd 
Main cortisol findings Main clinical findings Quality/ 
Relevance 
b
Barba-
doro et 
al. 
2013(60) 
To evaluate the effects of 
fish-oil on perceived 
stress/anxiety and HPA 
axis activity in abstinent 
alcoholics 
31 men with 
alcohol 
dependence 
attending 4-
week 
inpatient 
detoxification 
and 
rehabilitation 
programme 
1 capsule (1g) of 
fish oil per day x 
3 wks, 
commenced after 
completing 1 
week of 
medication-
supported 
detoxification 
1 placebo 
capsule per day 
x 3 wks, 
commenced 
after completing 
1 week of 
medication-
supported 
detoxification 
1) Self-perceived 
stress 
2) Basal salivary 
cortisol levels 
3) Salivary 
cortisol in 
response to the 
Trier Social Stress 
Test (results not 
presented here) 
3 wks 1 day 
5 sample points 
(7.30am, 
11.30am, 4pm, 
8pm, midnight) 
Time-specific 
cortisol levels  
There was a significant 
group x time interaction 
effect, with significant 
decreases in 7.30am, 8pm 
and midnight cortisol 
levels over time in the 
intervention group but not 
in the control group.   
There was a 
significant decrease in 
perceived stress in the 
intervention group but 
not in the control 
group.  
Moderate 
Camfield 
et al. 
2013 (61)  
To examine the 
relationship between 
chronic multivitamin 
supplementation, diurnal 
cortisol secretion and 
stress in healthy adults.  
138 healthy 
adults 
1 multivitamin 
tablet per day for 
16 wks 
1 placebo tablet 
per day for 16 
wks 
1) Salivary 
cortisol 
2) Perceived stress 
3) Plasma 
homocysteine, Vit 
B12, Vit B6 and 
folate 
16 wks 1 day 
4 sample points 
(On awakening, 
15 min and 30 
min after 
awakening, 
bedtime) 
1) CAR, measured 
as the maximum 
value out of the 15 
and 30 min samples 
minus the waking 
waking 
2) Time-specific 
cortisol levels, in 
particular morning 
and evening values 
There was a significant 
group x time interaction 
effect for CAR, with an 
increase in CAR in the 
intervention group and a 
decrease in CAR in the 
control group at 16 wks 
Perceived stress 
increased significantly 
in both groups over 16 
weeks, with no 
significant difference 
between the two 
groups 
Moderate 
Cha-
borski et 
al. 2015 
(62) 
To investigate the effects 
of a specific amino-acid 
mixture in combination 
with micronutrients in 
psychologically stressed 
adults attending a 
cardiology outpatient 
service.  
(pilot study) 
34 
psychological
ly stressed 
adults 
attending a 
cardiology 
outpatient 
service.  
1 serving of a 
nutritional 
supplement per 
day (8.9 g powder 
dissolved in 
200ml water) for 
12 wks. The 
supplement 
consisted of 
specific amino 
acids and 
micronutrients to 
target stress 
physiology.  
Placebo: 8.9g 
powder 
dissolved in 
200ml water per 
day for 12 wks.  
1) Psychological 
stress 
2) Salivary 
cortisol 
3) Blood pressure 
and heart rate 
4) Plasma 
serotonin, CRP, 
lipids and glucose 
indices.  
12 wks 1 day  
2 sample points 
(morning and 
evening) 
Time-specific 
cortisol levels 
There were no significant 
within-group or between 
group changes in the 
cortisol parameters.  
Psychological stress 
decreased significantly 
in both the 
intervention and 
placebo groups, with a 
significantly greater 
decrease in the 
placebo group.  
Moderate 
Deuschle 
et al. 
2003 (63) 
To study the effects of 
two different 
antidepressant classes on 
HPA axis activity in 
moderately to severely 
depressed inpatients 
126 adult 
inpatients 
with 
moderate-
severe 
depression 
Paroxetine 
(selective 
serotonin-reuptake 
inhibitor) x 35 
days (increased to 
40mg after the 
Amitriptyline 
(tricyclic 
antidepressant) 
x 35 days 
(increased to 
150mg per day 
1) Depression 
(Hamilton 
depression rating 
scale) 
2) Salivary 
cortisol 
5 wks Participants 
were instructed 
to collect saliva 
daily for 35 
days and 
samples were 
Time-specific 
cortisol level: the 
mean cortisol level 
for each timepoint 
was calculated for 
each week 
There was evidence of 
declining cortisol values 
over time in both groups, 
with no significant 
difference between groups 
without taking treatment 
There was a decrease 
in depression in both 
groups with no 
significant difference 
over time between 
groups.  
Moderate 
first week) after the first 
week) 
analysed in 
weekly blocks. 
Participants had 
to provide a 
minimum of 3 
days of samples 
per week for 
inclusion in the 
analysis.  
Sample points:  
(8am, 4pm, 
10pm) 
response into account. 
However, there was a 
significant group x time x 
response interaction effect, 
with only clinical 
responders to Amitriptyline 
showing significantly 
lower levels of 8am and 
4pm cortisol levels over 
the 5 wks.  
Eijsbouts 
et al. 
2008 (64) 
To investigate whether 
Naproxen has a direct or 
indirect effect on HPA 
axis activity 
40 healthy 
volunteers 
Naproxen 
capsules 500mg 
orally twice daily 
x 2 wks 
Placebo 
capsules orally 
twice daily x 2 
wks 
1) Basal salivary 
cortisol 
2) Basal  urine 
cortisol 
3) Basal plasma 
cortisol and 
ACTH 
3) Plasma cortisol 
and ACTH 
response to 
exercise 
2 wks 1 day 
6 sample points 
over 24 hours 
(08am, noon, 
4pm, 8pm, 
midnight, 4am) 
 AUC There was no significant 
difference in AUC between 
the two groups before and 
after treatment.  
N/A Moderate 
Garrison 
and 
Cambliss
, 2006 
(65) & 
Kalman 
et al. 
2008 (66)  
To determine the efficacy 
of a dietary supplement 
ingredient containing 
proprietary extracts of 
Magnolia officinalis and 
Phellodendron amurense
in helping overweight 
premenopausal women 
manage their weight 
(pilot study) 
42 
overweight, 
otherwise 
healthy, 
premenopaus
al women 
who typically 
eat more in 
stressful 
situations and 
scored above 
the national 
mean for self-
reported 
anxiety 
250mg capsules 
(containing 
Magnolia 
officinalis and 
Phellodendron 
amurense
extracts) three 
times per day for 
6 weeks 
Identical 
placebo 
capsules 
1) Salivary 
cortisol 
2) Weight 
3) Psychological 
measures of stress 
and anxiety 
6 wks 3 days 
3 sample points 
(On awakening, 
30 min post 
awakening, at 
bedtime) 
1) Overall mean 
diurnal cortisol 
level: average of 9 
measurements over 
3 days 
2) Average morning  
cortisol level: over 3 
days 
3) Average 30 min 
cortisol level 
4) Average evening 
cortisol level 
No statistically significant 
within-group change for 
any cortisol parameter, 
regardless of intervention, 
from baseline to 6 weeks 
1) Statistically 
significant increase in 
weight in the placebo 
group with no 
significant change in 
the treatment group 
2) Statistically 
significant 
improvement in 
psychological 
measures in both 
treatment and placebo 
groups 
Moderate 
Hinkel-
mann et 
al. 2012 
(68)  
To investigate if changes 
in cortisol secretion 
during antidepressant 
treatment are associated 
with improvement in 
cognition 
This study objective was 
a secondary objective 
within a separately 
reported proof-of-concept 
RCT [Otte et al.(81)] 
designed to investigate 
whether adjunctive 
treatment with a 
mineralocorticoid 
receptor (MR) agonist or 
antagonist accelerates the 
onset of action and 
improves the efficacy of 
Escitalopram.  
52 adult 
patients with 
major 
depression 
All patients were 
commenced on 
Escitalopram 10-
20mg for 3 weeks. 
They were then 
randomised to 
receiving either 
Fludricortisone 
(n=19), 
Spironolactone 
(n=22) or placebo 
(n=11) add-on 
therapy 
The comparison 
of the 3 ‘add-on’ 
treatments was not 
relevant to the 
study objective 
outlined in this 
paper. 
Within-group 
effects of 
Escitalopram on 
cortisol, 
cognition and 
depression were 
compared to an 
age and sex-
matched healthy 
control group.  
1) Salivary 
cortisol 
2) 
Neuropsychologic
al measures of 
cognition 
3) Depression 
scale 
3 wks 1 day 
4 sample points 
(8am, 12pm, 
4pm, 10pm) 
AUC  AUC decreased 
significantly after 3 weeks 
of Escitalopram 
1) Significant 
improvement in 
depression after 3 
weeks of Escitalopram 
(returned to healthy 
control level) 
2) Significant 
improvement in some 
cognitive variables 
after 3 weeks of 
Escitalopram in 
comparison with the 
healthy control group 
Moderate 
Hellweg 
et al. 
2008 (67)  
To compare changes in 
serum levels of brain-
derived neurotrophic 
factor (BDNF) and nerve 
growth factor (NGF) in 
depressed subjects after 
antidepressant treatment.  
A secondary aim was to 
40 inpatients 
with a 
diagnosis of 
major 
depressive 
disorder 
Amitriptyline 
150mg once daily 
x 36 days 
Paroxetine 
40mg once 
daily x 36 days 
1) Serum BDNF 
2) Serum NGF 
3) Depression 
measure 
4) Salivary cortisol 
5 wks 6 days  
2 sample points 
(8am and 4pm) 
Time-specific 
cortisol level 
There were no significant 
changes between or within 
groups for salivary cortisol 
levels 
Depression scores 
improved significantly 
in both groups with no 
significant difference 
between groups. There 
was a significant 
increase in BDNF in 
the Amitriptyline 
group in comparison 
Moderate 
examine the relationship 
between neurotrophin and 
salivary cortisol changes. 
with the Paroxetine 
group. There were no 
significant changes in 
NGF. 
ann. behav. med.
Table 2 (continued)
Knorr et 
al. 
2012(70) 
To explore the specific 
pharmacodynamic effect 
of Escitalopram on 
hypothalamic-pituitary-
adrenal (HPA) activity 
compared to placebo in 
healthy participants 
80 healthy 
first-degree 
relatives of 
patients with 
depression 
(aged 18-60 
years) 
Escitalopram 
10mg once daily x 
4 weeks 
Placebo tablets 
once daily x 4 
weeks 
1) Salivary 
cortisol 
2) Perceived stress 
3) Depression 
scale 
4) Anxiety scale 
5) Pain scale 
6) Sleep scale 
7) Quality of life 
scale 
8) Aggression 
scale 
4 wks 1 day 
8 sample points 
(On awakening, 
followed by 15, 
30, 45 and 60 
min post-
awakening, and 
at 12.00, 18.00 
and 23.00) 
1) CAR:  measured 
by AUC for the first 
hour 
2) Total AUC for 
the day 
There was a significant 
decrease in the CAR AUC 
(P=0.04) and the all-day 
cortisol AUC (P=0.02) in 
the Escitalopram group 
compared to the placebo 
group. However, when a 
correction was made for 
multiple outcome 
measures, this finding did 
not reach statistical 
significance.  
There was no 
significant change in 
clinical outcome 
measures between the 
two groups 
High 
Lenze et 
al. 2011 
(71) & 
Lenze et 
al. 2012 
(72) 
To investigate the impact 
of Escitalopram versus 
placebo on the HPA axis 
in older adults with 
generalised anxiety 
disorder (GAD)  
95 older 
adults (≥60 
years) with 
GAD 
Escitalopram 
10mg once daliy x 
12 weeks 
Placebo x 12 
weeks 
1) Salivary 
cortisol 
2) Anxiety 
measures 
3) Cognitive 
measures 
12 wks 2 days 
6 sample points 
(On awakening, 
30 min after 
awakening, 
noon, 4pm, 
8pm, bedtime) 
1) Peak cortisol 
level: defined as the 
cortisol level 30 min 
after awakening 
2) AUC 
There was a significant 
reduction in peak cortisol 
in the Escitalopram group 
in comparison with the 
placebo group. This was 
most marked for the 
subgroup with elevated 
cortisol levels at baseline.  
The authors did not 
provide a report of the 
within or between 
group changes for the 
anxiety and cognitive 
measures. However, 
there was a significant 
association between 
improvement in 
memory and reduction 
in cortisol indices in 
Moderate  
the Escitalopram 
group. In addition, 
subgroup analysis 
indicated a significant 
association between 
change in cortisol 
indices and change in 
anxiety for those with 
high baseline cortisol 
levels.  
Lopresti 
et al. 
2015(73) 
To explore the effects of 
Curcumin for the 
treatment of major 
depression on blood, 
urinary and salivary 
biomarkers.  
Non-biological outcomes 
reported in Lopresti et al. 
(86) 
50 adults with 
currently 
major 
depressive 
disorder  
Curcumin capsule 
500mg twice daily 
x 8 wks 
Placebo capsule 
500mg twice 
daily x 8 wks 
1) Depression 
2) Anxiety 
3) Salivary 
cortisol 
4) A range of 
other biomarkers 
in urine and 
plasma 
8 wks 1 day 
2 sample points 
(within 10 min 
of awakening 
and 30 min 
later) 
1) CAR 
2) Awakening 
cortisol 
3) 30 min cortisol  
There were no significant 
group x time interaction 
effects for the any of the 
cortisol parameters over 8 
wks 
There were no 
significant group x 
time interaction effects 
for anxiety or 
depression scores over 
the 8 wks, with a 
reduction in both 
groups. However, the 
reduction in symptoms 
was greater in the 
Curcumin group from 
4 to 8wks.  
Moderate 
Mocking 
et al. 
2014 (75) 
To investigate the effect 
of varenicline on the HPA 
axis, in order to explore 
potential depressogenic 
effects at the biological 
level.  
(Varenicline is a partial 
nicotinergic 
acetylcholinergic receptor 
agonist)  
41 healthy 
never-
smoking 
volunteers 
Varenicline 1 
capsule per day on 
days 1-3 and day 
7 and two 
capsules per day 
on days 4-6.  
Placebo 
capsules in the 
same schedule.  
Salivary cortisol 1 wk 1 day 
3 sample points 
(On awakening, 
15 min and 30 
min after 
awakening) 
CAR: sample 
moment was entered 
as a factor in the 
repeated measures 
ANOVA analysis 
There was no significant 
group x treatment or group 
x treatment x ‘sample 
moment’ effect, indicating 
that there was no 
significant change in CAR 
between groups.  
N/A Moderate 
Nonino-
Borges et 
al. 2007 
(76) 
To determine the 
influence of meal time on 
salivary circadian cortisol 
rhythm and weight loss in 
obese women  
(Crossover design) 
12 obese, 
otherwise 
healthy, 
women  
Hypocaloric diet 
served between 
9am and 11am  
OR  
Hypocaloric diet 
served between 
6pm and 8pm  
Five 
hypocaloric 
meals per day 
spread 
throughout the 
day from 9am 
to 8pm 
1) Salivary cortisol 
2) BMI and body 
composition 
measurements 
3) Resting 
metabolic rate 
4) Urinary 
nitrogen 
18 
days 
1 day 
6 sample points 
(8am, 12 noon, 
5pm, 7pm, 9pm, 
and 8am the 
following 
morning) 
1) Presence or 
absence of a 
circadian rhythm, 
defined as a 9pm 
value of  <90% of 
the morning cortisol 
value 
2) Mean diurnal 
cortisol 
concentration 
The diurnal cortisol rhythm 
was preserved from day 1 
to day 18 in all groups, 
with no significant change 
observed. 
There was no significant 
difference in mean cortisol 
concentration between 
groups at day 1 or day 18 
There were significant 
reductions in most 
measures of body 
compositions from day 
1 to day 18 in all 
groups but no 
significant difference 
between groups. 
Moderate 
Scharn-
holtz et 
al. 2010 
(78) 
To test the hypothesis that 
the HPA system-
dampening effects of 
venlafaxine and 
mirtazapine differ.  
Crossover study 
95 patients 
with a major 
depressive 
episode 
Venlafaxine daily 
in flexible doses x 
4 wks (minimum= 
75mg per day) 
Mirtazapine 
daily in flexible 
doses x 4 wks 
(minimum= 
30mg per day) 
1) Depression 
(Hamilton 
Depression Rating 
Scale) 
2) Salivary 
cortisol 
4 wks 1 day per wk, 
each week over 
5 wks 
2 sample points 
(8am, 4pm) 
Time-specific 
cortisol level 
There was a significant 
decrease in 4pm cortisol 
levels in the Mirtazapine 
group from baseline to 
week 4. There were no 
significant changes in 
cortisol levels at 8am or 
4pm in the Venlafaxine 
group.  
There was no 
significant difference 
between groups in 
relation to remission 
frequency over time. 
In addition, the decline 
in cortisol in the 
Mirtazapine group 
occurred in both 
‘remitters’ and ‘non-
remitters’ suggesting 
that the clinical effects 
and cortisol effects of 
Mirtazapine are 
unrelated.  
Moderate 
Schmidt 
et al. 
2015 (79) 
To explore the effects of 
two prebiotics on the 
secretion of cortisol and 
on emotional processing 
in healthy volunteers 
48 healthy 
volunteers  
One of two 
prebiotics:  
1) Fructo-
oligosaccharides 
(FOS)  
OR 
2) Bimuno-
galacto-
oligosaccharides 
(B-GOS)  
5.5g of powder 
with breakfast per 
day x 3 wks 
Placebo: 5.5g 
powder per day 
with breakfast x 
3 wks 
1) Salivary 
cortisol 
2) Processing of 
emotional stimuli  
3) Perceived stress 
3 wks 1 day 
5 sample points 
(On awakening, 
every 15 min 
after awakening 
for 1 hour) 
CAR: modelled in 
ANOVA with 
sample-moment as a 
within-subject factor 
and also calculated 
as AUC with respect 
to ground.  
There was a significant 
decrease in CAR in the B-
GOS group in comparison 
with placebo over 3 wks.  
The B-GOS group 
showed significantly 
increased attentional 
vigilance to positive 
versus negative stimuli 
in comparison with 
placebo.  
High 
Schubert 
et al. 
2011 (80)  
To investigate the effect 
of high-content milk-
based phospholipids on 
HPA axis activity and 
reactivity in chronically 
stressed men. 
(Details relevant to HPA 
75 healthy 
adult non-
smokers with 
elevated 
chronic stress 
scores at 
screening 
(screening 
Milk drink 
containing 0.5% 
phospholipid (1 
carton per day 
over 42 days) 
OR 
Milk drink 
containing 1% 
Placebo milk 
drink (1 carton 
per day over 42 
days) 
Salivary cortisol 6 wks 3 days  
4 sample points 
(On awakening 
and 30 min, 45 
min, 60 min 
after waking) 
CAR measured by 
subtracting the 
‘awakening level’ 
from the 60 min 
level 
There were no significant 
findings for CAR 
N/A Moderate 
axis activity only 
described here) 
questionnaire
=Trier 
inventory for 
Chronic 
Stress) 
phospholipid (1 
carton per day 
over 42 days) 
Ruhe et 
al. 2015 
(77) 
To examine the 
longitudinal effects of the 
SSRI, paroxetine, on 
salivary cortisol in major 
depressive disorder.  
42 patients 
with major 
depressive 
disorder who 
were 
identified as 
Paroxetine dose 
escalation every 5 
days up to a 
maximum of 
50mg per day 
Placebo dose 
escalation. 
These patients 
continued on 
paroxetine 
20mg per day 
1) Clinical 
response- 
primarily 
depression 
measured by the 
Hamilton 
6 wks  1 day 
2 sample points 
(On awakening, 
30 min after) 
1) Awakening 
cortisol level 
(referred to as 
‘baseline cortisol 
level’)  
2) CAR: 30min 
There were no significant 
group x time interaction 
effects for any of the 
cortisol parameters 
There was no 
statistically significant 
difference in remission 
rate between the two 
groups with a 
remission rate of 
Moderate 
A randomised controlled 
sub-study was nested 
within this larger 
longitudinal study, 
commencing after 6 wks 
follow-up and continuing 
for another 6 wks. We 
describe the RCT 
component only.  
non-
responders 
following 
treatment 
with 
paroxetine 
20mg per day 
over 6 wks in 
the larger 
cohort study.  
and were given 
placebo 
capsules during 
the dose-
escalation 
phase.  
Depression Rating 
Scale 
2) Salivary 
cortisol 
value minus the 
awakening value 
3) CAR AUC: 
awakening value + 
(1/2xCAR) 
14.3% in the dose-
escalation group and 
9.5% in the placebo-
dose-escalation group.  
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73.1 %) collected saliva over 1 day only. Ten studies used pro-
tocols of 2 days, eight used protocols of 3 days and three used
protocols of 4–6 days. The median number of samples collected
per day was 4 (IQR 3–5), ranging from a minimum of two
samples per day (n=12) to a maximum of nine samples per
day (n=3). Seventeen studies (21.8 %) collected six or more
samples per day. There was substantial variation in the timings
of the samples per day. Importantly, of the 75 studies which
reported sample times, only 49 (62.8 %) included an awakening
sample, suggesting that many studies did not use waking time as
a reference for subsequent diurnal sampling points, choosing
clock times in preference.
Awide range of different salivary diurnal cortisol parameters
were analysed both within and across studies. In relation to com-
posite measures of diurnal cortisol, the cortisol awakening re-
sponse was measured in 25 studies (32.1 %), the area under the
curve from morning to evening was measured in 22 studies
(28.2%) and the diurnal decline/slopewasmeasured in 18 studies
(23.1 %). Five studies (6.4 %) modelled the diurnal profile using
multi-level modelling techniques, obviating the need to calculate
these composites separately. It was also common for studies to
report on changes in mean cortisol levels across the day (18,
23.1 %) or changes in absolute cortisol levels as specific times
during the day (34, 43.7 %). The majority of studies
(42, 53.8 %) used just one of these methods of
analysing and reporting diurnal cortisol, but 25 studies
(32.1 %) used two methods and 11 studies (14.1 %)
used three or more methods.
Overall, 39 studies (50 %) measured an indicator of circa-
dian rhythm by calculating either a cortisol awakening re-
sponse or a diurnal slope or by modelling the diurnal profile.
Interestingly, this proportion differed between study interven-
tion categories: psychosocial intervention studies (22/33,
66.7 %), pharmacological studies (8/22, 36.4 %) and comple-
mentary therapy studies (7/14, 50 %). Only nine studies
(11.5 %) calculated both the cortisol awakening response
and the diurnal slope. In addition, however, five studies
modelled these simultaneously using multi-level modelling
techniques, suggesting that 14 studies in total (17.9 %)
analysed both indicators of HPA axis regulation. Only two
studies (2.6 %) used all three diurnal profile parameters (cor-
tisol awakening response, diurnal slope and area under the
curve) as recommended by Adam et al. for epidemiological
studies [11].
Table 2 (continued)
Talbott et 
al. 2013a 
(81) 
To study the effects of 
‘Tongkat Ali’ 
supplementation (South 
East Asian “anti-aging” 
medicinal herb) in 
moderately stressed 
adults. 
63 
moderately 
stressed 
adults 
Tongkat Ali (TA) 
herbal medicine 
200mg per day x 4 
wks 
‘Look-alike’ 
placebo daily x 
4 wks 
1) Mood state 
(primary) 
2) Salivary 
cortisol (primary) 
3) Salivary 
testosterone 
(primary) 
4) Liver enzymes 
5) Body weight 
6) Body fat 
percentage 
4 wks 1 day 
3 sample points 
(morning, 
afternoon, 
evening) 
Mean diurnal 
cortisol level 
Mean cortisol level was 
significantly lower in the 
treatment group compared 
to placebo at 4 wks. 
However, mean cortisol 
appeared to increase in 
both groups over the 4 
wks.  
There was a 
significant reduction in 
anger, tension, and 
confusion in the 
treatment group 
compared with the 
placebo group at 4 
wks, but no significant 
change in depression, 
vigour, fatigue and 
overall wellbeing. 
Moderate  
Talbott et 
al. 2013b 
(82) 
To study the effects of 
‘Relora’ (combination of 
magnolia bark and 
phellodendron bark) on 
salivary cortisol and 
psychological well-being 
in healthy adults with 
stress.  
60 healthy 
adults with 
stress 
Relora 250mg per 
day, at breakfast 
and dinner time, x 
4 wks 
‘Look-alike’ 
placebo in the 
same schedule x 
4 wks 
1) Body fat 
percentage 
2) Body weight 
3) Stress 
4) Mood state 
5) Salivary 
cortisol 
4 wks  1 day 
3 sample points 
(on awakening-
approx 6am, 
afternoon-
approx 2pm, 
evening- approx 
10pm) 
Mean diurnal 
cortisol level 
(‘cortisol exposure’) 
Authors indicate that 
the ‘circadian 
rhythm data’ will be 
reported elsewhere 
Salivary cortisol exposure 
was significantly lower in 
the treatment group at 4 
wks. Change data not 
reported.  
At 4 wks, global mood 
state and overall stress 
were significantly 
lower in the treatment 
group. No differences 
existed for body 
composition 
parameters.  
Moderate 
Tucker et 
al. 2004 
(83) 
To explore the effects of 
a selective serotonin-
reuptake inhibitor (SSRI) 
versus placebo on cortisol 
and cytokines in patients 
with chronic PTSD 
59 patients 
with chronic 
PTSD 
Citalopram 20-
50mg per day x 10 
wks 
OR
Sertraline 50-
200mg per day x 
10 wks 
Placebo pill 
identical in 
appearance x 10 
wks 
1) Salivary 
cortisol 
2) Serum 
interleukins (IL-
1β, IL-2R) 
3) PTSD 
symptoms 
4) Depression 
10 wks 1 day 
2 sample points 
(8am, 4pm) 
Time-specific 
cortisol levels 
There were no significant 
changes in cortisol levels 
in either of the treatment 
groups. There was a 
significant increase in 4pm 
cortisol in the placebo 
group over 10 wks.  
There was a 
significant 
improvement in PTSD 
and depression 
symptoms in all 3 
groups, including the 
placebo group.  
Moderate 
Walsh et 
al. 2006 
(84) 
To evaluate the impact of 
enhanced slow-wave 
sleep on behavioural, 
psychological and 
physiological changes 
associated with sleep 
restriction 
41 healthy 
adults 
subjected to 4 
nights of 
sleep-
restriction 
Tiagabine 8mg x 
4 nights, during 
sleep restriction 
Placebo x 4 
nights, during 
sleep restriction 
1) Poly-
somnography 
2) Multiple Sleep 
Latency Test 
3) Vigilance 
4) Mood 
5) Sleepiness 
6) Learning, 
memory, 
perception & 
cognition tests 
7) Heart rate 
variability 
8) Salivary 
7 days 1 day 
8 sample points  
(hourly 
sampling from 
2.20pm to 9.20 
pm) 
1) Mean overall 
cortisol  
2) AUC 
Mean diurnal cortisol and 
cortisol AUC increased 
significantly in the placebo 
group relative to the 
treatment group over the 7 
days. 
Tiagabine significantly 
increased slow-wave 
sleep as measured by 
polysomnography. 
This was accompanied 
by better scores on key 
executive function 
tests.  
Moderate 
cortisol 
9) Urinary 
catecholamines 
Wit-
bracht et 
al. 2013 
(85) 
To determine the 
influence of energy 
restriction and dairy food 
consumption on salivary 
cortisol in obese women  
51 
overweight 
(otherwise 
healthy) 
females who 
were 
habitually 
low-dairy 
consumers 
Low amount of 
dairy food, with 
energy 
restrictions, for 15 
weeks 
Adequate 
amount of dairy 
food, with 
energy 
restrictions, for 
15 weeks 
1) Salivary cortisol 
2) Weight loss 
3) Fat loss 
12 wks 1 day 
6 basal sample 
points  
(On awakening, 
15 min after 
awakening, 
prior to lunch, 
prior to dinner, 
at 7.45pm  and 
prior to bed) 
1) CAR (measured 
by subtracting 15 
min sample from 
awakening sample) 
2) Time-specific 
cortisol level 
3) Mean diurnal 
cortisol level 
4) Minimum cortisol 
5) Maximum 
cortisol  
6) Amplitude of 
cortisol profile  
7) Variance of 
cortisol 
In the overall sample (data 
from both groups 
combined), there was a 
significant increase in 
minimum cortisol and a 
significant decrease in 
amplitude of cortisol. 
There was no significant 
difference between groups 
for any of the basal cortisol 
parameters 
Both groups lost 
weight and fat due to 
energy restriction but 
there was no 
significant difference 
between groups for 
these parameters 
Moderate 
Shaded rows represent studies with agreement between clinical and cortisol findings
aDescribes the number of consecutive days of sampling and the number of samples per day per time-point
bAssessed using Gough’s Framework
cRefers to the number and type of participants randomised
dAbbreviations used for cortisol summary measures: CAR, cortisol awakening response; AUC, area under the curve.
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Table 3 Randomised controlled trials evaluating complementary therapies: study characteristics, salivary cortisol methodology and main findings
Study ID Main study objective(s) Study 
Populationc 
Intervention Comparator 
or Control 
Main outcome 
measures 
Assess-
ment 
period  
Saliva 
collection 
protocola 
Diurnal cortisol 
parameters 
analysedd
Main cortisol findings Main clinical findings Quality/ 
Relevance 
b
Banasik 
et al. 
2011 (86) 
To examine the effect of 
regular Iyengar yoga 
practice on self-perceived 
psychosocial function and 
diurnal salivary cortisol 
in breast cancer survivors 
(pilot) 
18 stage II-IV 
breast cancer 
survivors 
Yoga practice 
delivered in 90 
min sessions twice 
weekly for 8 wks 
Waiting list x 8  
wks 
1) Salivary 
cortisol 
2) Perceived 
quality of life 
(FACT B) 
8 wks 2 days 
4 sample points 
(morning, noon, 
5pm, 10pm) 
1) Time-specific 
cortisol levels 
2) Diurnal slope 
There were no significant 
group x time interaction 
effects for any of the 
cortisol parameters.  
Pre-post within- group 
analysis indicated that 
morning and 5pm cortisol 
levels decreased 
significantly at 8 wks in 
the yoga group, with no 
significant changes in the 
control group.  
There was a 
significant group x 
time interaction effect 
for fatigue score, 
decreasing over time 
in the yoga group and 
increasing over time in 
the control group.  
Pre-post within group 
analysis indicated that 
emotional wellbeing 
and fatigue improved 
significantly at 8 wks 
in the yoga group, 
with no significant 
changes in the control 
group.  
Moderate 
Billhult 
et al. 
2008 (87) 
To study the effect of 
repeated effleurage 
massage on cellular 
immunity in patients with 
breast cancer. The study 
of its effect on cortisol 
was a secondary aim.  
22 women 
who had 
recently 
undergone 
surgery for 
breast cancer 
and were 
about to 
commence 
adjuvant 
radiotherapy 
Effleurage 
massage therapy 
delivered in 10 
sessions over 3-4 
weeks, each 
session taking 
place immediately 
after a scheduled 
radiation 
treatment.  
Unstructured 
conversation 
with the 
massage 
therapist but no 
massage, 
following the 
same time 
schedule as the 
intervention 
group.  
1) Biomarkers of 
immunity 
2) Salivary 
cortisol 
3) Plasma 
oxytocin 
4) Anxiety, 
depression and 
quality of life.  
4 wks 1 day 
2 sample points  
(6am and 10pm) 
No information 
provided but 
presumed to have 
used time-specific 
cortisol levels.  
There were no significant 
changes in cortisol 
between groups 
There were no 
significant changes in 
any of the non-cortisol 
outcome measures 
between groups 
Moderate 
Bower et 
al. 2014 
(88) 
To examine the effects of 
Iyengar yoga on genomic 
and circulating markers 
of inflammation in 
fatigued breast cancer 
survivors.  
This was a secondary 
objective of the RCT 
described. The primary 
objective of examining 
the effects of Iyengar 
yoga on fatigue and 
associated results are 
31 stage 0-II 
breast cancer 
survivors, at 
least 6 
months post-
treatment, 
suffering 
from cancer-
related 
fatigue 
Iyengar yoga 
delivered in 90 
min sessions twice 
weekly over 12 
wks 
Health 
education 
classes 
delivered in 120 
min sessions 
once a week 
over 12 wks  
1) Self-reported 
fatigue 
2) Psychological: 
depression, sleep, 
stress 
3) Disease-related 
and function-
related measures 
4) Gene 
expression 
profiling 
5) Plasma 
inflammatory 
markers 
24 wks 2 days 
4 sample points 
(on awakening, 
30 min and 8 
hrs after 
awakening, 
bedtime) 
1) Diurnal slope 
2) AUCg (excluding 
30 min value) 
There were no significant 
group x time interaction 
effects for diurnal slope or 
AUC and there were no 
significant changes in these 
parameters in the pre-post 
within group analysis.  
There was a 
significant decrease in 
fatigue severity at 12 
wks and 24 wks in the 
yoga group relative to 
the control group.  
High 
reported in Bower et al. 
(98).  
6) Salivary 
cortisol 
Campo et 
al. 2015 
(90) 
To assess the effect of tai 
chi chih (TCC) on blood 
pressure, salivary cortisol 
and inflammatory 
cytokines in senior 
female cancer survivors. 
This was a secondary 
objective of the RCT 
described. The primary 
objective was to assess 
the feasibility, 
acceptability and health-
related quality of life 
outcomes of tai chi chih 
(TCC) in senior female 
cancer survivors; the 
results relating to this 
objective are reported in 
Campo et al. 2013 (100).  
(feasibility) 
63 senior 
female cancer 
survivors, the 
majority 
surviving 
breast cancer  
TCC delivered in 
60 min sessions, 3 
days per wk, over 
12 wks 
Health 
education 
delivered in 50 
min sessions, 3 
days per wk, 
over 12 wks 
1) Feasibility and 
acceptability 
2) Quality of life 
3) Blood pressure 
4) Salivary 
cortisol 
5) Inflammatory 
cytokines 
13 wks 1 day 
5 sample points 
(On awakening, 
30 min after 
awakening, 
noon, 5pm and 
10pm) 
1) CAR 
2) Diurnal slope 
(from the 30 min 
sample to the 10pm 
sample) 
3) AUC 
The AUC was significantly 
lower in the intervention 
group relative to the 
comparator at 12 wks. 
There were no significant 
differences for the other 
parameters.  
Quality of life scores 
did not differ 
significantly between 
groups at 12 wks. A 
large proportion of 
participants in both 
groups showed an 
improvement.  
Moderate 
Chand-
wani et 
al. 2014 
(92) 
To investigate the long-
term effects of yoga in 
women with breast cancer 
undergoing radiotherapy 
178 women  
with stage 0-
III breast 
cancer being 
scheduled to 
undergo a 6-
wk course of 
radiotherapy 
Yoga classes 
lasting 60min  up 
to 3 times weekly 
for 6 wks during 
radiotherapy 
Stretching 
classes lasting 
60 min up to 3 
times weekly 
for 6 wks 
during 
radiotherapy 
OR 
Waiting list 
control group 
1) Quality of life 
(physical and 
mental component 
scales) 
2) Fatigue 
3) Sleep 
disturbances 
4) Depression 
5) Salivary 
cortisol 
30 wks  3 days 
5 sample points 
(On awakening, 
45 min, 8 hrs 
and 12 hrs after 
waking, 
bedtime) 
1) Diurnal slope  
(without the waking 
sample) 
2) Waking cortisol 
levels 
The yoga group had a 
significantly steeper slope 
than the stretching and 
waiting list groups at 6 wks 
but this was not significant 
when missing data was 
imputed using a multiple 
imputation technique.  
There was a 
significant increase in 
the physical 
component scale score 
in the yoga group 
relative to the waiting 
list group at 1 and 3 
months after treatment 
completion (10wks 
and 18 wks from 
baseline). There was 
also a significant 
decrease in fatigue in 
both the yoga groups 
and stretching groups 
compared with the 
waiting list group at 6 
wks.  
High 
Corey et 
al. 2014 
(94)  
To investigate the effect 
of restorative yoga on 
psychosocial and cortisol 
outcomes in adults with 
metabolic syndrome  
Metabolic outcomes for 
this RCT are reported in 
Kanaya et al. 2014 (103) 
180 adults 
with 
metabolic 
syndrome 
Restorative yoga 
classes: 90 min 
classes  twice 
wkly for the first 
12 wks, once wkly 
for the next 12 
wks and then once 
monthly for 
another 6 months 
Stretching 
classes: 90 min 
classes  twice 
wkly for the 
first 12 wks, 
once wkly for 
the next 12 wks 
and then once 
monthly for 
another 6 
months 
1)Salivary cortisol 
2) Depression 
3) Self-reported 
social support 
4) Positive affect 
5) Self-reported 
stress 
1 year 
overall 
but 24 
wks for 
cortisol 
3 days 
4 sample points 
(On awakening, 
30 min and 60 
min after 
waking, 
bedtime) 
1) Diurnal slope: 
waking cortisol 
minus evening 
cortisol (averaged 
over 3 days) 
2) Cortisol percent 
change: evening 
cortisol minus 
waking cortisol 
divided by waking 
cortisol 
3) Time-specific 
cortisol levels  
4) Mean cortisol 
There was a significant 
decrease in mean cortisol, 
waking cortisol and 
evening cortisol in the 
stretching group compared 
to the restorative yoga 
group. There were no other 
significant changes 
between groups at 6 
months, controlling for 
baseline cortisol.  
There were no 
significant between-
group changes for any 
of the psychosocial 
variables at 6 months. 
Within-group pre-post 
analysis identified 
significant decreases 
in the severity of 
stressor and cognitive 
stress subscales in the 
stretch group at 6 wks, 
but not in the yoga 
group.  
High 
Danu-
calov et 
al. 2013 
(96) 
To investigate whether a 
yoga and compassion 
mediation program 
(YCMP)  alters stress, 
anxiety and depression 
levels in familial 
caregivers of patients 
with Alzheimer’s disease 
53 familial 
caregivers of 
patients with 
Alzheimer’s 
disease 
Yoga and 
compassion 
meditation 
programme 
(YCMP) delivered 
in 1.25 hr 
sessions, 3 times 
wkly over 8 wks 
Non-treatment 
control group.  
These 
participants 
were offered the 
treatment upon 
study 
completion.  
1) Self-reported 
stress 
2) Depression 
3) Anxiety 
4) Salivary 
cortisol 
8 wks 2 days 
2 sample points 
(On awakening 
and 30min 
after) 
1) Mean of the two 
samples on day 1  
2) Mean of the two 
samples on day 2 
3) Mean of day 1 
and day 2 means 
There was a significant 
reduction in mean morning 
cortisol (mean of day 1 and 
2) in the intervention group 
in comparison with the 
control group.   
There was a 
significant 
improvement in stress-
related symptoms and 
a reduction in anxiety 
and depression in the 
YCMP group in 
comparison to the 
control group 
Moderate 
Chen et 
al. 2013 
(93)  
To examine the efficacy 
of a qigong intervention 
on quality of life in 
women with breast cancer 
during and after 
radiotherapy.  
96 women 
with breast 
cancer who 
were 
scheduled to 
received 
Qigong delivered 
in once wkly 40 
min classes during 
5-6 wks of 
radiotherapy 
treatment.  
Waiting list 
control group 
1) Depression 
2) Fatigue 
3) Sleep 
disturbance 
4) Overall quality 
of life 
18 wks 2 days 
4 sample points 
(On awakening, 
45 min and 8 
hours after 
1) Diurnal slope: 
cortisol level 
regressed against 
sample time 
2) CAR: 45 min 
value minus 
There were no significant 
group x time interaction 
effects for diurnal slope or 
CAR.  
There was a 
significant group x 
time interaction effect 
for depressive 
symptoms, with a 
significant reduction in 
High 
radiotherapy 5) Salivary 
cortisol rhythm 
waking, 
bedtime) 
awakening value the treatment group 
relative to the waiting 
list group over 3 
months.  
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Cortisol Findings: Overall Patterns Across Studies
and Patterns Within Intervention Categories
Of the 78 included studies, 40 (51.2 %) reported a significant
within- or between-group difference in at least one cortisol pa-
rameter in response to the experimental intervention or compar-
ator. The significant effects for cortisol parameters were reported
at a variety of different follow-up time-points from baseline,
ranging from 1 week [38] to 72 weeks [56]. Fifty per cent
occurred at a median of 6 weeks from baseline (IQR 4–12).
Seventy-four studies reported both cortisol and clinical
findings, and these findings were in agreement in only
50 % of cases; these studies are shaded in Tables 1, 2, 3
and 4. The rate of agreement between clinical and corti-
sol findings differed between study intervention catego-
ries: psychosocial interventions (11/32, 34.4 %), pharma-
cological studies (11/20, 55 %) and complementary
therapy studies (9/13, 69 %). In most cases of disagree-
ment, significant effects for clinical outcome measures
were not accompanied by significant effects for cortisol
measures (25/37, 67.5 %). In some cases, significant ef-
fects were found for cortisol measures without significant
effects for clinical measures (10/37, 27 %), and in two
cases, significant effects occurred at different time-points
for the two types of measures.
As expected, due to wide heterogeneity across studies in
multiple domains (e.g. interventions, populations and cortisol
parameters), it was not possible or meaningful to summarise
the cortisol findings across all studies. Therefore, as an exam-
ple of the type and range of findings reported, we chose to
compare and contrast the cortisol outcomes for one study pop-
ulation, the breast cancer population, following similar inter-
ventions. This population was chosen as a number of larger
RCTs have been conducted in this population in recent years,
Table 3 (continued)
Huang et 
al. 2012 
(98) 
To explore the use the  
diurnal profile of salivary 
cortisol concentration as a 
marker of changes in 
stress following 
traditional Chinese 
acupuncture (TCA)  and 
to evaluate whether TCA 
normalises the diurnal 
salivary cortisol profile in 
18 adult 
volunteers 
with high 
self-reported 
stress levels 
Traditional 
Chinese 
Acupuncture 
(TCA) delivered 
over 5 weeks 
OR 
Attention only 
delivered over 5 
weeks 
Waiting list 
group x 5 weeks 
n=6 
1) Salivary cortisol 
2) Perceived stress 
7 wks 1 day 
4 sample points 
(On awakening, 
30 min after 
waking, 3 hours 
after waking 
and 12 hours 
after waking) 
1) CAR: awakening 
value subtracted 
from the 30 min 
value 
2) Diurnal slope: 12 
hour valued 
subtracted from 
awakening value 
3) Mean daytime 
cortisol level: 
There were no significant 
findings for cortisol 
parameters. However, there 
was a non-significant 
increase in CAR in both 
the acupuncture and 
attention groups.  
There was no 
significant difference 
within or between 
groups for perceived 
stress score.  
Moderate 
chronically stressed 
adults 
(exploratory study) 
average of 
awakening, 3 hour 
and 12 hour values 
Ragha-
vendra et 
al. 2009 
(99) 
To determine the effects 
of a yoga program (versus 
comparator) on stress and 
HPA axis function in 
patients with non-
metastatic breast cancer 
88 women 
with stage II 
and stage III 
breast cancer 
undergoing 
adjuvant 
radiotherapy 
Integrated yoga 
program delivered 
over 6 weeks 
Brief supportive 
therapy 
delivered over 6 
weeks 
1) Psychological 
measures 
including anxiety, 
depression and 
perceived stress 
2) Salivary cortisol 
6 wks 3 days 
3 sample points 
(6am, 9am, 
9pm) 
1) AUC 
2) ’Pooled mean 
diurnal cortisol’ 
level over the 3 days 
3) Time-specific 
cortisol levels 
There was a significant 
reduction in 6.00am 
cortisol and pooled mean 
diurnal cortisol in the 
intervention group in 
comparison with the 
control  
There was a 
significant reduction in 
anxiety, depression 
and perceived stress 
measures in the 
intervention group in 
comparison with the 
control  
Moderate 
Schneid-
er et al. 
2007 
(100) 
To evaluate the effect of 
acupuncture on the 
neuroendocrine and 
autonomic nervous 
system in patients with 
irritable bowel syndrome.  
This was a secondary 
analysis of an RCT 
evaluating the efficacy of 
acupuncture and reported 
in Schneider et al. 2006 
(108).  
43 adults with 
irritable 
bowel 
syndrome 
Acupuncture 
delivered twice 
per week over 5 
weeks 
Sham 
acupuncture 
delivered twice 
per week over 5 
weeks 
1) Salivary 
cortisol 
2) Autonomic 
function 
3) Quality of life  
5 wks  1 day  
4 sample points 
(7am, 12 noon, 
5pm, 10pm) 
Time-specific 
cortisol level  
There was a significant 
decrease in salivary 
cortisol level at each 
collection time after the 
intervention but not after 
the control.  
There was a 
significant increase in 
parasympathetic tone 
in the intervention 
group in comparison 
with the control but 
there was no 
significant difference 
between the groups in 
quality of life.  
Moderate 
Tornhage 
et al. 
2013 
(102) 
To assess cortisol 
concentrations before, 
during and immediately 
after tactile massage in 
patients with Parkinson’s 
Disease (short-term and 
long-term effects) 
45 patients 
with 
Parkinson’s 
Disease  
Tactile massage: 2 
sessions per wk 
for the first 3 wks, 
then 1 session per 
wk for 4 wks 
Rest to music: 
same schedule 
and setting 
Salivary cortisol 
1) Diurnal (long-
term effects) 
2) Immediate pre-
post measures 
before and after 1st
and 8th
intervention  
Details of 
collection 
schedule and 
parameters for 
diurnal 
measurements 
recorded here only 
34 wks 1 day for 
diurnal cortisol 
4 sample points 
over 24 hours:  
8am, 1pm, 8pm 
and 8am the 
following 
morning 
1) Total daytime 
secretion: AUC 
from 8am to 8pm 
2) Total night-time 
secretion: AUC 
from 8pm to 8am 
3) Median cortisol 
concentration 
4) Time-specific 
cortisol levels 
There no significant 
changes in cortisol levels 
or AUC within or between 
groups over the follow-up 
period.  
N/A Moderate 
Woods et 
al. 2009 
(103) 
To examine the effect of 
therapeutic touch on 
behavioural symptoms in 
people with dementia 
65 people 
with a 
diagnosis of 
dementia 
Therapeutic touch 
for 5-7 min 
delivered twice 
daily for 3 days. 
After 5 days, this 
was treatment was 
repeated as a 
Placebo 
therapeutic 
touch: same 
touch process 
but without 
meditative 
approach, 
1) Observed 
behavioural 
symptoms using a 
validated scale 
2) Salivary 
cortisol 
16 
days 
Samples were 
collected daily 
over the 20 day 
study period, 
which was 
divided into 5 
time periods for 
Mean daily cortisol 
level: average of the 
4 sample points 
There was no significant 
group x time interaction 
effect.  
There was no 
significant group x 
time interaction effect 
for the behavioural 
symptoms, though 
pairwise comparisons 
indicated a significant 
Moderate 
booster.  delivered in 
same schedule 
OR 
Routine care 
analysis. This 
suggests that, 
on average, the 
sample period 
was over 4 
days.  
4 sample points 
(on awakening, 
30 min, 6 hours 
and 12 hours 
after 
awakening) 
decrease in 
restlessness in the 
treatment group in 
comparison with the 
control, but not the 
placebo.  
Hodgson 
and 
Lafferty, 
2012 
(97) 
To investigate and 
compare the effects of 
reflexology and Swedish 
massage therapy on 
physiologic stress, pain 
and mood in older cancer 
survivors residing in a 
nursing home (crossover 
design) 
(pilot study) 
18 nursing 
home 
residents, ≥ 
75 years, 
diagnosed 
and treated 
for cancer 
within the 
past 5 years  
Reflexology 
provided in 4 
sessions over 4 
weeks 
Swedish 
Massage 
provided in 4 
sessions over 4 
weeks 
1) Salivary 
cortisol  
2) Pain  
3) Mood 
4 wks 1 day 
4 sample 
points 
(7-7.30am, 11-
11.30am, 1-
1.30pm and 4-
4.30pm) 
Mean diurnal 
cortisol level across 
the day 
There was a significant 
within-group reduction in 
mean cortisol level for both 
groups but no significant 
difference between groups.  
There were significant 
changes in negative 
affect, positive affect 
and pain within both 
groups 
Moderate 
Shaded rows represent studies with agreement between clinical and cortisol findings
aDescribes the number of consecutive days of sampling and the number of samples per day per time-point
bAssessed using Gough’s Framework
cRefers to the number and type of participants randomised
dAbbreviations used for cortisol summary measures: CAR, cortisol awakening response; AUC, area under the curve.
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Table 4 Randomised controlled trials evaluating a range of ‘other’ interventions: study characteristics, salivary cortisol methodology and main
findings
Study ID Main study objective(s) Study 
Populationc 
Intervention Comparator 
or Control 
Main outcome 
measures 
Assess-
ment 
period  
Saliva 
collection 
protocola 
Diurnal cortisol 
parameters 
analysedd
Main cortisol findings Main clinical findings Quality/ 
Relevance 
b
Boelens 
et al. 
2009 
(104) 
To investigate the effect 
of direct person-to-person 
prayer on depression, 
anxiety, positive 
emotions and salivary 
cortisol levels 
(Parallel RCT with option 
of control group 
crossover into 
intervention group after 6 
weeks) 
63 adults with 
signs/sympto
ms of 
depression 
and/or 
anxiety 
(either self-
reported or 
referred by 
doctor/nurse) 
Prayer 
intervention 
delivered for 1 
hour per week 
over 6 weeks 
Non-treatment 
control 
1) Depression and 
anxiety measures 
2) Measures of life 
orientation and 
spiritual 
experiences 
3) Salivary cortisol 
10 wks 1 day 
4 sample points 
(8am, 12 noon, 
5pm, 9pm) 
AUC There were no significant
differences within or 
between groups in relation 
to cortisol AUC 
There was a 
significant 
improvement in 
depression, anxiety, 
spiritual experiences 
and life orientation 
scores in the 
intervention group in 
comparison with the 
control group at 6 
weeks 
Moderate 
Dudgeon 
et al. 
2012 
(105) 
To determine the effect of 
a low-volume, moderate-
intensity resistance and 
aerobic exercise training 
programme in HIV-
infected men 
59 men 
infected with 
HIV 
Low-volume, 
moderate intensity 
resistance and 
aerobic exercise 
training: 2 
sessions per week 
over 6 weeks 
Non-treatment 
control.  
Offered the 
treatment upon 
study 
completion. 
1) Physical 
activity 
2) Salivary 
cortisol 
3) Blood 
cytokines 
3) Body 
composition 
4) Peak strength 
5) Girth 
6 wks 1 day 
3 sample points 
(On awakening, 
1 hour and 2 
hours after 
waking) 
Time-specific 
cortisol levels  
There was a significant 
decrease in waking cortisol 
concentration in the 
exercise group.  
There was a 
significant increase in 
lean tissue mass and 
upper and lower body 
strength in the exercise 
group.  
Moderate 
Emery et 
al. 2005 
(106) 
To evaluate the influence 
of exercise on wound 
healing and whether the 
stress system is a possible 
mechanism by which it 
acts 
28 sedentary 
older adults 
(55-77 years) 
who agreed to 
a punch 
biopsy  
1 hour exercise 
sessions for 3 
days per week 
over 3 months 
Non-exercise 
control 
1) Wound healing 
2) Exercise 
endurance 
3) Salivary cortisol 
4) Perceived stress  
12 wks 2 days 
4 sample points 
(no further 
details) 
 AUC There was no significant 
difference between groups 
for salivary cortisol 
parameters  
Wounds in the 
exercise group healed 
significantly faster 
than wounds in the 
control group 
Moderate 
Jaggers 
et al.  
2014 
(107) 
To examine the effects of 
combined aerobic and 
resistance training on 
mood, stress and 
symptoms in HIV-
infected adults 
93 HIV-
infected 
males and 
females 
Only 49 
completed the 
study and a 
subsample of 
20 provided 
saliva 
samples 
Aerobic (30 min) 
and resistance (20 
min) training 
sessions twice 
weekly over 6 
wks 
Attended the 
centre, 
following the 
same time 
schedule, and 
engaged in 
sedentary 
activities.  
1) Mood 
2) HIV symptom 
distress 
3) Perceived stress 
4) Salivary 
cortisol 
6 wks 1 day 
3 sample points 
(on awakening, 
1 hour and 2 
hours after 
waking) 
Morning AUC  There was a significant 
decrease in morning AUC 
in the treatment group, 
which was not observed in 
the control.  
There was a 
significant decrease in 
mood disturbance in 
the intervention group, 
which was not 
observed in the 
control. There were no 
significant changes in 
the other clinical 
measures.  
Moderate 
Lieverse 
et al. 
To determine the efficacy 
of bright light treatment 
89 outpatients 
≥ 60 years 
BLT (bright pale 
blue light) 
Placebo (dim 
red light) 
1) Depression 
scale (primary) 
6 wks 1 day 1) Morning cortisol 
AUC (9am-1pm) 
There was a significant 
decrease in evening 
There was a 
significant 
High 
2011 
(108)  
(BLT) in elderly patients 
with major depressive 
disorder  
with major 
depressive 
disorder 
delivered for 1 
hour each 
morning over 3 
weeks 
delivered each 
morning over 3 
weeks 
2) Urinary cortisol 
3) Salivary 
cortisol 
4) Salivary 
melatonin 
5) Sleep 
actigraphy 
parameters 
8 sample points:  
4 morning 
samples at 30 
min intervals, 
starting 30 min 
after awakening 
4 evening 
samples at 
hourly intervals 
starting 4 hours 
before bedtime 
2) Evening cortisol 
AUC (5 to 9pm) 
cortisol AUC in the BLT 
group in comparison with 
the placebo group at 6 
weeks but not at 3 weeks.  
improvement in 
depression scores in 
the BLT group in 
comparison with the 
placebo group, at 3 
and 6 weeks 
Saxton et 
al. 2014 
(109) 
To investigate the effects 
of a pragmatic lifestyle 
intervention on indices of 
psychological health 
status, HPA axis 
regulation and immune 
function in overweight 
women recovering from 
early-stage breast cancer.  
Other outcomes reported 
in Scott et al. 2013 (117)  
85 women 
treated for 
early-stage 
breast cancer 
3-18 months 
previously, 
with a body 
mass index > 
25kg/m2 
A pragmatic 
lifestyle 
intervention was 
implemented over 
24 wks, which 
involved 3 
supervised 
exercise sessions 
per week along 
with an 
individually 
tailored 
hypocaloric 
healthy eating 
programme.  
Non-treatment 
control: offered 
exercise 
sessions and 
dietary advice 
upon 
completion of 
the study 
1) Depression 
2) Perceived stress 
3) Salivary 
cortisol 
4) Plasma cortisol 
5) Plasma 
cytokines/ 
lymphocyte 
profiling 
24 wks 3 days 
4 sample points 
(8am, 12 noon, 
5pm, 9pm) 
AUC: calculated 
using trapezoidal 
rule 
There was a significant 
increase in cortisol AUC in 
the intervention group in 
comparison with the 
control group at 24 wks, 
attributable to a higher 
morning cortisol in the 
intervention group post-
intervention.  
Depressive symptoms 
were significantly 
reduced in the 
intervention group in 
comparison with the 
control group at 24 
wks. However, there 
was no significant 
reduction in perceived 
stress in the 
intervention group in 
comparison with the 
control.  
High 
Scherder 
et al. 
2003 
(111)  
To investigate the effects 
of low-frequency cranial 
electrostimulation on rest-
activity rhythm and 
salivary cortisol levels in 
patients with probable 
Alzheimer’s Disease 
16 older 
adults living 
in residential 
homes with a 
probable 
diagnosis of 
Alzheimer’s 
Disease 
Cranial electrical 
stimulation (low-
frequency) 
administered for 
30min per day, 5 
days per week, 
over 6 weeks 
Placebo: 
apparatus 
attached but no 
current 
administered; 
same schedule 
1) Rest-activity 
rhythm 
(Actigraphy) 
2) Salivary 
cortisol 
12 wks 1 day 
9 sample points 
(Measures 
obtained at 
irregular times 
from 8am to 
10pm) 
A multi-level model 
was constructed 
resulting in a mean 
cortisol curve for 
each group at each 
follow-up point 
There was no significant 
time x group interaction 
effect for salivary cortisol 
outcomes 
There was no 
significant time x 
group interaction for 
rest-activity outcomes 
High  
Scherder 
et al. 
2006 
(112) 
To investigate the effects 
of high-frequency cranial 
electrostimulation on rest-
activity rhythm and 
salivary cortisol levels in 
patients with probable 
Alzheimer’s Disease 
20 older 
adults living 
in residential 
homes with a 
probable 
diagnosis of 
Alzheimer’s 
Disease 
Cranial electrical 
stimulation (high-
frequency) 
administered for 
30 min per day, 5 
days per week, 
over 6 weeks 
Placebo: 
apparatus 
attached but no 
current 
administered 
1) Rest activity 
rhythm 
(Actigraphy) 
2) Salivary 
cortisol  
12 wks 1 day 
9 sample points 
(Measures 
obtained at 
irregular times 
from 7.28am to 
11pm) 
A multi-level model 
was constructed 
resulting in a mean 
cortisol curve for 
each group at each 
follow-up point 
There was no significant 
time x group interaction 
effect for salivary cortisol 
outcomes 
There was no 
significant time x 
group interaction for 
rest-activity outcomes  
High 
Tam et 
al. 2014 
(113)  
To test the hypothesis that 
moderate caloric 
restriction (CR) by diet or 
a combination of diet and 
34 young 
overweight 
adults 
Calorie restriction 
(25% reduction in 
energy intake) 
Control: weight 
maintenance 
group 
1) Body 
composition 
2) Blood lipids, 
glucose, leptin, 
24 wks 1 day 
8 sample points 
(8.00, 8.30, 
1) Morning cortisol: 
average of 8.00 and 
8.30 cortisol 
2) Mean diurnal 
There were no significant 
group x time interaction 
effects for morning cortisol 
or mean diurnal cortisol 
Body weight, fat mass 
and visceral adipose 
tissue were 
significantly reduced 
Moderate 
exercise would alter 
morning and diurnal 
cortisol.  
Metabolic outcomes of 
RCT separately reported 
in Heilbronn et al. 2006 
(121) 
OR 
Calorie restriction 
group with 
exercise (12.5% 
reduction in 
energy intake + 
12.5% increase in 
exercise) 
thyroxine, IGF-1 
3) Insulin 
sensitivity and 
acute insulin 
response to 
glucose 
4) Salivary 
cortisol 
11.00, 11.30, 
12.30, 13.00, 
16.00, 16.30) 
cortisol (‘diurnal 
cortisol’): average of 
8 samples across the 
day 
from baseline in both 
intervention groups in 
comparison with the 
control. There were 
also significant 
changes in some of the 
biochemical measures 
in the intervention 
groups in comparison 
with the control.   
Shaded rows represent studies with agreement between clinical and cortisol findings
a Describes the number of consecutive days of sampling and the number of samples per day per time-point
b Assessed using Gough’s Framework
c Refers to the number and type of participants randomised
dAbbreviations used for cortisol summary measures: CAR, cortisol awakening response; AUC, area under the curve.
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with many scoring ‘high’ in the quality and relevance assess-
ment. In addition, there is robust evidence that flatter diurnal
cortisol slopes in this population are associated with shorter
survival [3], pointing to the plausibility of the HPA axis as a
potential therapeutic target.
Four studies evaluated the effects of different psychosocial
interventions in patients with breast cancer. There was incon-
sistency between clinical and cortisol findings in two of these
studies. In addition, the types of cortisol parameters measured,
along with their patterns of change, were not uniform across
studies. Two studies, one evaluating mindfulness-based can-
cer recovery and supportive expressive therapy [25], and the
other evaluating mind-body-spirit therapy [34], found that the
diurnal slope remained unchanged in the treatments groups
but that it became significantly flatter in the control group,
suggesting that these treatments had a buffering effect on the
HPA axis. This finding corresponded with clinical findings in
only one of the studies [25], however. In another study eval-
uating mind-body-spirit therapy, there was no change in the
diurnal slope in either the treatment or the control groups, but
the area under the curve decreased in the treatment group,
mirroring a reduction in symptoms in this group [27]. A sim-
ilar intervention (relaxation and visualisation therapy) had no
effect on the area under the curve in another study, however,
despite a reduction in symptoms [48].
Four studies evaluated yoga in patients with prior or current
breast cancer. Banasik et al. [86] found no significant change in
the diurnal slope, despite an improvement in symptoms; howev-
er, absolute cortisol levels (morning and evening) were found to
be significantly reduced. Bower et al. [88] found that there was
no change in the diurnal slope or the area under the curve, despite
an improvement in symptoms. A further study found that, along
with symptom improvement, the diurnal slope became signifi-
cantly steeper over 6 weeks of treatment relative to comparator
groups; this finding lost significance, however, after missing
values were addressed using a multiple imputation technique
[92]. Finally, Raghavendra et al. [99] found a reduction in symp-
toms, 6.00 am cortisol concentration and ‘pooled mean diurnal
cortisol’ after yoga but no change in other time-specific cortisol
levels or in the area under the curve. All four of these studies
provide support for yoga in relation to symptom improvement,
but there was no consistent pattern of change in cortisol param-
eters across studies. The problem of interpreting cortisol findings
was further compounded by the use of a range of different cor-
tisol parameters both within and between studies.
Discussion
This systematic review characterises the types of RCTs which
have used salivary diurnal cortisol as an outcome measure for
the evaluation of health and behavioural interventions and
details the salivary diurnal cortisol methodology and findings
therein. To the authors’ knowledge, this is the first systematic
review of this kind.
The review highlights the increasing use of salivary diurnal
cortisol as an outcome measure in RCTs, particularly since
2012. The majority of these RCTs have evaluated psychosocial
or complementary therapy interventions in a wide range of
populations, ranging from healthy volunteers to patients with
cancer. With regard to salivary diurnal cortisol methodology
and outcomes, the review has identified the following findings:
(1) many of the RCTs screened did not use diurnal measures of
salivary cortisol, (2) the majority of RCTs measuring diurnal
cortisol collected samples over 1 day only, (3) there is wide
heterogeneity across studies in relation to sampling schedules,
(4) there is wide heterogeneity in relation to the cortisol profile
parameter chosen for analysis, with a large proportion of stud-
ies failing to analyse diurnal rhythm parameters, and (5) inter-
pretation of cortisol findings within and between RCTs is chal-
lenging due to the use of different parameters in different stud-
ies, varying cortisol change patterns across studies and high
levels of inconsistency between cortisol and clinical findings.
These review findings are discussed below, and based on these
findings, recommendations are made for the future incorpora-
tion of salivary diurnal cortisol into RCTs.
Many of the RCTs Screened Did Not Measure Diurnal
Cortisol Profiles
During the selection process, after excluding articles for
other reasons, 87 of the remaining 175 RCTs (50 %)
were excluded because they did not measure diurnal pro-
files of salivary cortisol, despite including it as an out-
come measure. In many cases, a single salivary cortisol
sample was obtained before and after an intervention,
either on the same day as the intervention was received
or on a different day. It is long established that single
measures of basal cortisol, even if collected at the same
time each day, have very low reliability due to signifi-
cant intra-individual variability [10]. For example, Coste
et al. [115] demonstrated that when a single salivary
cortisol sample was collected at 8 am at three time-
points over 5 weeks the intra-class correlation coefficient
(r) was as low as 0.18. In addition, single measures of
basal cortisol have very low diagnostic utility, due to
wide inter-individual variation, with normal ranges over-
lapping with abnormal ranges [10]. It is surprising that
despite this knowledge, which dates back to 1994, many
researchers are still using single measures of cortisol as
biomarkers within their trials. This practice has the po-
tential consequence of generating false positive results in
response to interventions, particularly within small pilot
studies. Apart from this, the use of unreliable measures
within RCTs is a waste of limited financial resources.
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The Majority of RCTs Collected Saliva Samples Over
1 Day Only
This review found that 57 out of the 78 included studies
(73.1 %) collected diurnal samples over 1 day only. When
the cortisol awakening response is measured on a single day,
it has been shown to be highly influenced by situational or
state factors, but reliable cortisol awakening response mea-
surements have been obtained when the cortisol awakening
response is averaged over at least 2 days [correlation coeffi-
cient (r) between 2-day pairs=0.7] [116]. Significant day-to-
day variation has also been observed for the diurnal slope,
where the frequencies of inconsistent diurnal patterns over
2–3 days were observed to be 31 % in one sample [117] and
43 % in another [118]. For these reasons, it is recommended
that salivary cortisol is collected over more than 1 day in order
to capture stable characteristics [11]. In fact, it has been sug-
gested that it is better to add more consecutive days to the
protocol than more samples per day in order to improve the
reliability of diurnal rhythm assessment [11]. Measures of low
reliability inevitably result in low validity. Therefore, the pre-
dominant lack of consecutive day sampling observed in this
review necessitates that cortisol outcomes within the included
RCTs be interpreted with caution. Indeed, the low level of
agreement between cortisol and clinical findings across the
RCTs (50%) might well be explained by the low reliability of
the diurnal profiles measured within these RCTs.
There Is Wide Heterogeneity Across Studies in Relation
to Sampling Schedules
Within the included studies, the number of samples collected
per day ranged from two samples per day to nine samples per
day, the median being 4 (IQR 3–5) samples per day. The wide
variation in protocols highlights the fact that there really is no
consensus regarding the optimal frequency of sampling per
day. Some of this is probably due to lack of knowledge in
the field of stress research about the impact of different sam-
pling schedules on diurnal profile validity. In their review,
Adam and Kumari [11] referred to unpublished data of theirs
which demonstrated that a 2-point diurnal slope (morning and
evening) correlates extremely well with a 6–7 point slope
(correlation coefficient=0.94), suggesting that delineating
the curve more precisely does not significantly improve the
accuracy of important summary measures such as the diurnal
slope. Whilst this data suggests that a minimal protocol of 2
collection points per day can yield a meaningful diurnal slope,
further validation studies are needed to confirm this and to
investigate the maximum number of samples per day beyond
which sampling would be wasteful and unnecessarily burden-
some. Considering that 21.8 % of RCTs in this review used a
schedule of 6 or more sampling points per day, this area of
uncertainty needs to be addressed promptly.
In addition to variation in sample number per day, sampling
times also differed between studies. For example, only 62.8 %
of studies included an awakening sample. As a result, in many
studies, the cortisol profile was anchored to clock time rather
than waking time, which is suboptimal practice. Whilst it is
preferable to calculate the diurnal slope using values outside
of the awakening period, the cortisol profile from which it is
derived should be anchored to waking time. The rationale for
this is well documented, the practice being based upon the fact
that waking up activates a burst of cortisol pulses which serve to
‘synchronise’ the circadian rhythm of the HPA axis [10]. Fur-
thermore, it has been shown that diurnal cortisol rhythms are
influenced primarily by personal sleep-wake cycles, predomi-
nantly wake time, rather than by dark-light cycles [11, 119].
There Is Wide Heterogeneity Across RCTs in Relation
to the Cortisol Profile Parameters Analysed
Despite rhythm parameters being most robustly linked with
health outcomes, it was surprising that only half of the RCTs
included a marker of diurnal rhythm by measuring either the
cortisol awakening response or the diurnal slope or by multi-
level modelling techniques. Interestingly, these measures were
most commonly used in studies measuring psychosocial inter-
ventions where the prevalence was 66.7 %. Lack of measure-
ment of these parameters within RCTs suggests little awareness
of the complexities of HPA axis regulation and function
amongst clinical trialists and points to the need to better trans-
late psychoneuroendocrinological knowledge into clinical trials
research. Better collaboration between basic scientists, in the
field of psychoneuroendocrinology, and clinical trialists, with
an interest in salivary cortisol as a biomarker, may help ame-
liorate this problem. The higher prevalence of rhythm parame-
ters in psychosocial intervention studies probably reflects the
already well-established relationship between the disciplines of
clinical psychology and psychoneuroendocrinology, owing to
the natural proximity of the fields.
It was uncommon for RCTs using rhythm parameters to
measure both the cortisol awakening response and the diurnal
decline (17.9 %) and even more uncommon for RCTs to mea-
sure all three parameters recommended by Adam and Kumari
[11] in epidemiological studies (the cortisol awakening re-
sponse, diurnal decline and area under the curve) (2.6 %). In
the context of RCTs, it would appear sensible to measure all
three parameters in order to robustly assess HPA axis activity,
particularly in the context of an exploratory study. In particu-
lar, it would make sense to measure both the cortisol awaken-
ing response and the diurnal slope given that they are believed
to be regulated independently, representing different aspects
of HPA axis function [14–16, 120]. Failure to measure all
parameters within an RCT may result in false negative find-
ings in relation to HPA axis function and may partially explain
the low agreement between cortisol and clinical findings in
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this review. On the other hand, where all three parameters are
used, it would be important to guard against the practice of
multiple testing and post hoc hypotheses. With this in mind, it
would be wise for RCTs to state the primary HPA axis param-
eter of interest, including its hypothesised direction of change,
in the protocol prior to commencing the study.
Studies which did not use rhythm parameters relied on ‘area
under the curve’ measures, mean diurnal cortisol measures or
absolute cortisol measures at specific times of the day to mea-
sure HPA axis activity. There are several disadvantages to these
approaches. In relation to the area under the curve, whilst it is a
useful measure of overall cortisol exposure, it is difficult to
interpret its meaning without a co-measure of diurnal rhythm.
This is because both hypocortisolism and hypercortisolism
have been linked with chronic stress and its health implications
[6], such that the amount of cortisol in the system has become a
less discerning instrument for measuring clinically relevant
stress. For the same reason, measurement of the mean cortisol
level across the day has similar limitations. The measurement
of absolute cortisol levels at specific times in the day and the
reporting of within- or between-group pre-post changes for
each specific time represented another approach. Due to the
separate analysis for each sample point, however, this is no
different, in many respects, to obtaining multiple single cortisol
measures, with each cortisol measure having low reliability. In
addition, with this approach, study findings are likely to be-
come contaminated by false positive findings due to the inev-
itable consequences of multiple analyses. Thus, the RCTs
which used this approach need to be interpreted with caution.
Interpretation of Cortisol Findings Within and
Between RCTs Is Challenging
Analysis of the cortisol findings for psychosocial intervention
studies and complementary therapy studies in the breast cancer
population demonstrated the challenge of interpreting cortisol
findings both within and between RCTs. This population, as a
whole, is believed to have a flatter diurnal slope than a healthy
population, and assuming this relates to chronic stress, one would
expect a stress-relieving intervention to result in a steeper slope.
No study was able to robustly demonstrate this, however. Instead,
the findings of two studies [25, 34] suggested that the diurnal
slopes would have become progressively flatter without interven-
tion, due to a pattern of progressively flattening slopes in the
control groups. In the absence of longitudinal studies of HPA axis
regulation over weeks, months and years, it is not possible to
firmly draw this conclusion, however. The findings of these stud-
ies illustrate the importance of understanding the natural history of
HPA axis regulation within the target population before evaluat-
ing the effects of interventions in RCTs. Without understanding
this, it is not possible to form a priori hypotheses regarding the
direction of change in a cortisol parameter in response to an
intervention. It may well be that stress-relieving interventions
serve to ‘stabilise’ the HPA axis and protect it from further dys-
regulation, but this can only occur in a population within which
unstable function or progressive HPA axis dysregulation exists.
Within studies, there was a high rate of inconsistency be-
tween clinical and cortisol findings, with cortisol findings
supporting clinical findings in only 50 % of studies. In many
cases, there was a significant clinical response to the interven-
tion but no cortisol response. This may have occurred for a
wide variety of reasons. The lack of cortisol response most
likely reflects flaws in the cortisol measurement methodology,
as discussed above. Lack of engagement of the HPA axis by the
intervention is also a possibility, indicating that the intervention
works by an alternative mechanism. Alternatively, it is possible
that ‘target engagement’ did occur but that the impact on cor-
tisol was obscured by the effects of other pathways and sys-
tems. Finally, another reason for lack of effect may be the
absence of HPA axis dysregulation at baseline in the sample
population receiving the intervention. For many of the studies,
the prevalence or degree of HPA axis dysregulation in the pop-
ulation at baseline was not clear; this would need to be high in
order to observe an improvement in HPA axis function after a
therapeutic intervention, particularly in the presence of many
confounders, as would be common in a patient population.
In a minority of cases of disagreement between findings,
positive cortisol findings occurred in the absence of clinical
findings. This may represent a time lag between HPA axis
restoration and clinical improvement, with HPA axis restora-
tion temporarily preceding clinical improvement. It may also
result from the use of inappropriate clinical outcome mea-
sures, resulting in false negative clinical findings. Alternative-
ly, however, this disagreement may reflect lack of reliability in
the cortisol measure, resulting in false positive cortisol find-
ings. Low reliability is highly likely for the studies included in
this review, given the high prevalence of 1-day saliva collec-
tion protocols. Along with short-term reliability issues, the
long-term stability of diurnal cortisol measures is also likely
to impact on results, and there is a growing literature to sug-
gest that this is low [17]. For example, Ross et al. [121]
analysed visit-to-visit cortisol stability for the diurnal cortisol
profile in a population of 46 healthy adults, providing 3-day
cortisol profile samples at 2.5 monthly visits over 8 months
and found only low-modest intra-class correlation coefficients
(ICC) for the cortisol awakening response (ICC 0.219), the
diurnal slope (ICC 0.473) and the area under the curve (ICC
0.556), with even lower stability at the individual level.
Due to heterogeneity across studies in relation to the HPA
axis parameters measured, it was difficult to explore the
timeframe over which a given parameter might be expected
to change following an intervention, which was an important
review aim. Nevertheless, the review has shed some light on
this area of uncertainty by identifying that changes in param-
eters occurred at a median of 6 weeks from baseline (IQR 4–
12). Though this finding needs to be interpreted with caution,
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given the wide heterogeneity across studies in relation to pa-
rameters used, intervention duration and follow-up schedule,
it at least provides a guide for the design of future RCTs in
relation to the optimal timing of the primary endpoint and the
length of the follow-up period.
Recommendations for the Future
In view of the increasing use of salivary diurnal cortisol as a
biomarker within RCTs and the marked heterogeneity in
practices and findings across studies, there is a clear need
for guidance on how best to incorporate this biomarker into
RCTs, in order to prevent unnecessary research costs and
participant burden. The high level of inconsistency between
clinical and cortisol findings and the difficulty in interpreting
cortisol change patterns suggests a need for further valida-
tion studies. There is also a need for greater precision in
diurnal cortisol measurement. Furthermore, there is a need
for greater uniformity in the collection and analysis of cor-
tisol, to allow findings to be compared across studies. We
have summarised recommendations towards the achieve-
ment of these goals in box 1.
Box 1. Recommendations for the use of salivary diurnal cor-
tisol as a biomarker within randomised controlled trials.
A. Decide whether or not it will be a useful biomarker:
• Establish the prevalence and pattern of HPA axis dysregulation in the
target population
•Establish the longitudinal change in the pattern of HPA axis activity over
the planned time-frame for the RCT
• Establish the construct validity of HPA axis parameters against relevant
clinical measures
• Be able to form an a priori hypothesis regarding the expected direction
of change in at least one HPA axis parameter in response to the
experimental intervention
B. Optimise the reliability and validity of the cortisol measure:
•Collect salivary cortisol over at least 2 days both before and at least once
after the intervention
• Collect all samples with reference to awakening time rather than a clock
time
• Ideally, include enough sample points in the day to analyse all three
parameters (the cortisol awakening response, the diurnal slope and the
area under the curve), to provide a full picture of HPA axis activity,
unless there are valid reasons to exclude some components (e.g.
expected high non-compliance rates for the cortisol awakening re-
sponse)
C. Optimise the ability to interpret and compare clinical trial findings:
• Choose one cortisol parameter as the primary cortisol outcome measure
(e.g. cortisol awakening response or area under the curve or diurnal
slope) in advance of the study, linking this with the a priori hypothesis;
this should be identified as the primary parameter in the protocol and
the published report.
• Include all other cortisol parameters as secondary outcome measures
Limitations
A number of methodological limitations need to be borne in
mind when interpreting the findings of this review. Firstly,
though we searched six electronic databases using sensitive
search terms for RCTs and salivary cortisol, we excluded an-
imal studies from three databases (MEDLINE, EMBASE and
AMED) using the exploded term, which, we realised in retro-
spect, may have inadvertently eliminated some human studies.
Having assessed the impact of this on the MEDLINE results,
however, we are confident that this has not had a significant
impact on the overall yield of eligible studies due to the sub-
stantial overlap of these databases with each other and with
both the Cochrane Central Register of Controlled Trials and
PsychINFO. Secondly, we did not perform a supplementary
manual literature search. Whilst this strategy may have im-
proved our yield of RCTs, given the very broad search criteria
in relation to type of intervention and population, it was not
feasible to devise a comprehensive manual search strategy
without biasing the study selection process.
Conclusions
This review systematically maps the literature which reports on
the use of salivary diurnal cortisol as an outcomemeasure within
RCTs. It demonstrates that there is wide heterogeneity across
RCTs in the methodology of salivary cortisol collection, and in
the profile parameters analysed. Furthermore, it has demonstrat-
ed that suchmethodological heterogeneity has consequences for
both the internal validity of individual trials and the ability to
compare and synthesise results across trials of similar interven-
tions. As such, it highlights a need for better validation of this
measure, more reliable approaches to measurement and the need
for greater collaboration between the disciplines of
psychoneuroendocrinology and applied science disciplines such
as medicine, psychology and nursing, with a view to better and
more prompt translation of basic science knowledge about HPA
axis measurement into clinical trials research.
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Appendixes
Appendix A Search strategy for systematic review.
MEDLINE (1980 to 21 May 2015):
1. cortisol.ti,ab;
2. saliva*.af;
3.1 AND 2;
4. HYDROCORTISONE/;
5. SALIVA/;
6.4 AND 5;
7. ‘randomized controlled trial’.pt;
8. ‘controlled clinical trial’.pt;
9. ‘randomized’.ab;
10. placebo.ab;
11. randomly.ab;
12. trial.ab;
13. groups.ab;
14. 7 OR 8 OR 9 OR 10 OR 11 OR 12 OR 13;
15. expANIMALS/
16. 14 NOT 15
17. 3 OR 6
18. 16 AND 17;180 results
CINAHL (1981 to 21 May 2015):
1. cortisol.ti,ab;
2. saliva*".af;
3. HYDROCORTISONE/;
4. SALIVA/;
5. 1 AND 2;
6. 3 AND 4;
7. 5 OR 6;
8. ‘randomized controlled trial’.pt;
9. ‘controlled clinical trial’.pt;
10. ‘clinical trial’.pt;
11. RANDOMIZED CONTROLLED TRIALS/OR CLINICAL
TRIALS/OR INTERVENTION TRIALS/;
12. randomized.ab;
13. placebo.ab;
14. randomly.ab;
15. trial.ab;
16. groups.ab;
17. 8 OR 9 OR 10 OR 11 OR 12 OR 13 OR 14 OR 15 OR 16;
18. 7 AND 17; 338 results
PsychINFO (1806 to 21 May 2015):
1 cortisol.ti,ab;
2. saliva*.af;
3. 1 AND 2;
4. HYDROCORTISONE/;
5. SALIVA/;
6. 4 AND 5;
7. 3 OR 6;
8. ‘randomised controlled trial’.pt
9. ‘controlled clinical trial’.pt
10. ‘clinical trial’.pt
11. TREATMENT EFFECTIVENESS EVALUATION/OR CLINICAL
TRIALS/;
12. randomized.ab;
13. placebo.ab;
14. randomly.ab;
15. trial.ab;
16. groups.ab;
17. 8 OR 9 OR 10 OR 11 OR 12 OR 13 OR 14 OR 15 OR 16;
18. 7 AND 17; 879 results
AMED (1985 to 21 May 2015)
1 cortisol.ti,ab;
2. saliva*.af;
3. 1 AND 2;
4. HYDROCORTISONE/;
5. SALIVA/;
6. 4 AND 5;
8. ‘randomized controlled trial’.pt
9. ‘controlled clinical trial’.pt
10. ‘clinical trial’.pt
11. CLINICALTRIALS/OR RANDOMIZED CONTROLLED
TRIALS;
12. randomized.ab;
13. placebo.ab;
14. randomly.ab;
15. trial.ab;
16. groups.ab;
17. 8 OR 9 OR 10 OR 11 OR 12 OR 13 OR 14 OR 15 OR 16;
18. expANIMALS/
19. 17 NOT 18
20. 3 OR 6
21. 19 AND 20; 11 results
EMBASE (1974 to 21 May 2015)
1 cortisol.ti,ab;
2. saliva*.af;
3. 1 AND 2;
4. HYDROCORTISONE/;
5. SALIVA/OR SALIVA ANALYSIS/OR SALIVA COLLECTOR/
6. 4 AND 5
7. 3 OR 6
8. ‘CLINICALTRIAL (topic)’/OR CONTROLLEDCLINICALTRIAL/
OR ‘CONTROLLED CLINICALTRIAL (topic)’/OR ‘PHASE 1
CLINICALTRIAL (topic)’/OR ‘PHASE 2 CLINICALTRIAL
(topic)’/OR ‘PHASE 3 CLINICALTRIAL (topic)’/OP ‘PHASE 4
CLINICALTRIAL (topic)’/OR ‘RANDOMIZED CONTROLLED
TRIAL (topic)’/
9. randomized.ab;
10. placebo.ab;
11. randomly.ab;
12. trial.ab;
13. groups.ab;
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14. 8 OR 9 OR 10 OR 11 OR 12 OR 13
15. expANIMAL/
16. 14 NOT 15
17. 16 AND 7;109 results
Cochrane Central Register of Controlled Trials (up to 21 May 2015)
1. cortisol
2. saliva*
3. Mesh descriptor: hydrocortisone
4. Mesh descriptor: saliva
5. (1 AND 2) OR (3 AND 4); 857 results
Appendix B Quality and relevance assessment using Gough’s
framework.
Study ID Weight of Evidence A
(Generic quality of
execution of study)
Weight of Evidence B
(Appropriateness of the study
design to the review aim)
Weight of Evidence C
(Focus of the study content
relative to the review aim)
Weight of Evidence D
(Overall quality and
relevance grade)
Banasik et al. 2011 [86] Low High High Moderate
Barbadoro et al. 2013[60] Moderate High Moderate Moderate
Bergen-Cico et al. 2014 [22] Moderate High High High
Billhult et al. 2008 [87] Moderate High Low Moderate
Boelens et al. 2009 [104] Low High Moderate Moderate
Bormann et al. 2009 [23] Moderate High Moderate Moderate
Bougea et al. 2013 [24] Low High Moderate Moderate
Bower et al. 2014 [88] Moderate High High High
Camfield et al. 2013 [61] Low High High Moderate
Campo et al. 2015 [90] Low High High Moderate
Carlson et al. 2013 [25] High High High High
Cash et al. 2014 [26] Moderate High High High
Chaborski et al. 2015 [62] Moderate High Moderate Moderate
Chan et al. 2006 [27] Moderate High Moderate Moderate
Chandwani et al. 2014 [92] Moderate High High High
Chen et al. 2013 [93] Moderate High High High
Corey et al. 2014 [94] Moderate High High High
Danucalov et al. 2013 [96] Moderate High Moderate Moderate
Delle Chiaie et al. 2012 [28] Low High High Moderate
Deuschle et al. 2003 [63] Moderate Low Moderate Moderate
Dudgeon et al. 2012 [105] Low High Moderate Moderate
Eijsbouts et al. 2008 [64] Moderate High Moderate Moderate
Emery et al. 2005 [106] Low High Moderate Moderate
Feicht al. 2013 [29] Low High Moderate Moderate
Gaab et al. 2006 [30] Moderate High High High
Garrison and Chambliss, 2006 [65]
& Kalman et al. 2008 [66]
Low High Moderate Moderate
Gex-Fabry et al. 2012 [31] High High High High
Hellweg et al. 2008 [67] Moderate High Moderate Moderate
Hinkelmann et al. 2012 [68] Moderate Moderate High Moderate
Hodgson and Lafferty, 2012 [97] Moderate High Moderate Moderate
Holt-Lunstad et al. 2008 [32] Moderate High Moderate Moderate
Hsiao et al. 2011 [33] Moderate High Moderate Moderate
Hsiao et al. 2012 [34] Low High High Moderate
Hsiao et al. 2014 [35] Low High High Moderate
Huang et al. 2012 [98] Low High High Moderate
Jaggers et al. 2014 [107] Low High Moderate Moderate
Jensen et al. 2012 [36] Moderate High Low Moderate
Klatt et al. 2009 [37] Low High Moderate Moderate
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